<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosbiol</journal-id>
<journal-title-group>
<journal-title>PLOS Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1544-9173</issn>
<issn pub-type="epub">1545-7885</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pbio.3000304</article-id>
<article-id pub-id-type="publisher-id">PBIOLOGY-D-19-00260</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Signal transduction</subject><subj-group><subject>Coreceptors</subject><subj-group><subject>CD coreceptors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Mammals</subject><subj-group><subject>Primates</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Mammals</subject><subj-group><subject>Primates</subject><subj-group><subject>Monkeys</subject><subj-group><subject>Old World monkeys</subject><subj-group><subject>Macaque</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Signal transduction</subject><subj-group><subject>Coreceptors</subject><subj-group><subject>CCR5 coreceptor</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Animal studies</subject><subj-group><subject>Experimental organism systems</subject><subj-group><subject>Animal models</subject><subj-group><subject>Rhesus monkeys</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Mammals</subject><subj-group><subject>Primates</subject><subj-group><subject>Monkeys</subject><subj-group><subject>Old World monkeys</subject><subj-group><subject>Macaque</subject><subj-group><subject>Rhesus monkeys</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Luminescent proteins</subject><subj-group><subject>Green fluorescent protein</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Selective use of primate CD4 receptors by HIV-1</article-title>
<alt-title alt-title-type="running-head">Selective use of primate CD4 receptors by HIV-1</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4101-2705</contrib-id>
<name name-style="western">
<surname>Warren</surname>
<given-names>Cody J.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Meyerson</surname>
<given-names>Nicholas R.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3523-3352</contrib-id>
<name name-style="western">
<surname>Dirasantha</surname>
<given-names>Obaiah</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Feldman</surname>
<given-names>Emily R.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3773-1064</contrib-id>
<name name-style="western">
<surname>Wilkerson</surname>
<given-names>Gregory K.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6965-1085</contrib-id>
<name name-style="western">
<surname>Sawyer</surname>
<given-names>Sara L.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>BioFrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Comparative Medicine, Michale E. Keeling Center for Comparative Medicine and Research, The University of Texas MD Anderson Cancer Center, Bastrop, Texas, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Hope</surname>
<given-names>Thomas J.</given-names>
</name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Northwestern University Feinberg School of Medicine, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">ssawyer@colorado.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2019</year>
</pub-date>
<volume>17</volume>
<issue>6</issue>
<elocation-id>e3000304</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-year>2019</copyright-year>
<copyright-holder>Warren et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pbio.3000304"/>
<abstract>
<p>Individuals chronically infected with HIV-1 harbor complex viral populations within their bloodstreams. Recently, it has come to light that when these people infect others, the new infection is typically established by only one or a small number of virions from within this complex viral swarm. An important goal is to characterize the biological properties of HIV-1 virions that seed and exist early in new human infections because these are potentially the only viruses against which a prophylactic HIV-1 vaccine would need to elicit protection. This includes understanding how the Envelope (Env) protein of these virions interacts with the T-cell receptor CD4, which supports attachment and entry of HIV-1 into target cells. We examined early HIV-1 isolates for their ability to infect cells via the CD4 receptor of 15 different primate species. Primates were the original source of HIV-1 and now serve as valuable animal models for studying HIV-1. We find that most primary isolates of HIV-1 from the blood, including early isolates, are highly selective and enter cells through some primate CD4 receptor orthologs but not others. This phenotype is remarkably consistent, regardless of route of transmission, viral subtype, or time of isolation post infection. We show that the weak CD4 binding affinity of blood-derived HIV-1 isolates is what makes them sensitive to the small sequence differences in CD4 from one primate species to the next. To substantiate this, we engineered an early HIV-1 Env to have high, medium, or low binding affinity to CD4, and we show that it loses the ability to enter cells via the CD4 receptor of many primate species as the binding affinity gets weaker. Based on the phenotype of selective use of primate CD4, we find that weak CD4 binding appears to be a nearly universal property of HIV-1 circulating in the bloodstream. Therefore, weak binding to CD4 must be a selected and important property in the biology of HIV-1 in the body. We identify six primate species that encode CD4 receptors that fully support the entry of early HIV-1 isolates despite their low binding affinity for CD4. These findings will help inform long-standing efforts to model HIV-1 transmission and early disease in primates.</p>
</abstract>
<abstract abstract-type="toc">
<p>The current animal model for HIV, the macaque, encodes a CD4 receptor that is non-permissive for HIV entry. This paper reveals that six primate species encode CD4 receptors compatible with HIV infection, potentially making them powerful tools for the study of HIV biology. Furthermore, weak CD4 binding is a nearly constant, and apparently selected, property of HIV circulating in the human bloodstream.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000026</institution-id>
<institution>National Institute on Drug Abuse</institution>
</institution-wrap>
</funding-source>
<award-id>DP1-DA-046108</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6965-1085</contrib-id>
<name name-style="western">
<surname>Sawyer</surname>
<given-names>Sara L.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>R01-AI-137011</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6965-1085</contrib-id>
<name name-style="western">
<surname>Sawyer</surname>
<given-names>Sara L.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000861</institution-id>
<institution>Burroughs Wellcome Fund</institution>
</institution-wrap>
</funding-source>
<award-id>PATH</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6965-1085</contrib-id>
<name name-style="western">
<surname>Sawyer</surname>
<given-names>Sara L.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>T32 AI007447-25</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4101-2705</contrib-id>
<name name-style="western">
<surname>Warren</surname>
<given-names>Cody J.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award005">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000057</institution-id>
<institution>National Institute of General Medical Sciences</institution>
</institution-wrap>
</funding-source>
<award-id>F32-GM-125442</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4101-2705</contrib-id>
<name name-style="western">
<surname>Warren</surname>
<given-names>Cody J.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award006">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000861</institution-id>
<institution>Burroughs Wellcome Fund</institution>
</institution-wrap>
</funding-source>
<award-id>PDEP</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Meyerson</surname>
<given-names>Nicholas R.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award007">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000057</institution-id>
<institution>National Institute of General Medical Sciences</institution>
</institution-wrap>
</funding-source>
<award-id>F32-GM-123878</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Feldman</surname>
<given-names>Emily R.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This research was funded by NIH grants DP1-DA-046108 and R01-AI-137011 to SLS. SLS is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease. CJW is supported by NIH fellowships F32-GM-125442 and T32-AI-007447. NRM is a Burroughs Wellcome Fund PDEP fellow. ERF is supported by NIH fellowship F32-GM-123878. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<page-count count="26"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2019-06-20</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Individuals chronically infected with HIV-1 harbor complex viral populations within their bloodstreams. Recently, it has come to light that when these people infect others, the new infection is typically established by only one or a small number of virions from within this complex viral swarm [<xref ref-type="bibr" rid="pbio.3000304.ref001">1</xref>]. This appears to be true for transmission mediated by all modes, including sexual transmission, mother-to-child transmission, and intravenous infection via needle sharing [<xref ref-type="bibr" rid="pbio.3000304.ref001">1</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>]. The virus populations in newly infected individuals often start off as genetically homogenous and match a strong consensus sequence during the first days and weeks after transmission [<xref ref-type="bibr" rid="pbio.3000304.ref003">3</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>]. Only over time does viral diversity begin to bloom. The critical question is whether the virions that seed and establish new infections possess unique biological properties or whether transmission is simply so inefficient that it produces an extreme (but random) genetic bottleneck. Indeed, recent studies show that virions isolated from early in infection do have some unique biological properties, and this is still an active area of research [<xref ref-type="bibr" rid="pbio.3000304.ref003">3</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref005">5</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref010">10</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref015">15</xref>]. If it continues to be substantiated that early isolates have unique properties, prophylactic vaccines will only need to overcome this special subset of HIV-1, curtailing the significant problem that global viral diversity presents to vaccine design. This simplification of the problem has fueled new hope for the long-elusive HIV-1 vaccine.</p>
<p>Primates have played a critical role in the history of HIV-1 [<xref ref-type="bibr" rid="pbio.3000304.ref016">16</xref>]. HIV-1 originated from the zoonotic transmission of a simian immunodeficiency virus (SIV) to humans [<xref ref-type="bibr" rid="pbio.3000304.ref017">17</xref>], and HIV-1 disease and transmission is now modeled in primates in the lab [<xref ref-type="bibr" rid="pbio.3000304.ref018">18</xref>]. The natural reservoir of SIV in African primates is ancient, with over 40 primate species being endemically infected with unique SIVs [<xref ref-type="bibr" rid="pbio.3000304.ref017">17</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref019">19</xref>]. It has been proposed that the long-term coevolutionary history between primates and SIVs may have affected the evolutionary trajectory of the CD4 gene [<xref ref-type="bibr" rid="pbio.3000304.ref020">20</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref021">21</xref>], which encodes the main cell surface receptor for both HIV and SIV. The CD4 gene has experienced numerous rounds of natural selection in favor of new allelic versions, specifically favoring sequence change at the virus-binding surface of the molecule [<xref ref-type="bibr" rid="pbio.3000304.ref020">20</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref021">21</xref>]. The most rapidly evolving residues in CD4 fall at the interaction interface with the HIV-1 surface protein Envelope (Env) (<xref ref-type="fig" rid="pbio.3000304.g001">Fig 1A</xref>). One model to explain this evolutionary signature is that primate individuals harboring CD4 alleles resistant to SIV infection have a selectable advantage compared to their peers. While SIV can probably mutate to bypass most receptor blocks, there will not be significant pressure to do so until a substantial number of hosts harbor CD4 alleles resistant to SIV infection. In this way, evolutionary arms races can unfold even though hosts and viruses have starkly different evolutionary rates (for a review on this topic, see [<xref ref-type="bibr" rid="pbio.3000304.ref027">27</xref>]). Indeed, we and others have observed that many host receptors have evolved under intense selective pressure to modify virus–host interaction interfaces [<xref ref-type="bibr" rid="pbio.3000304.ref016">16</xref>, <xref ref-type="bibr" rid="pbio.3000304.ref022">22</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref026">26</xref>]. Despite speculation regarding the significance of the unusual evolutionary signatures in CD4 [<xref ref-type="bibr" rid="pbio.3000304.ref020">20</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref021">21</xref>], a comprehensive functional comparison of CD4 from different primate species has not been conducted since an appreciation has been gained for the special properties of early HIV-1 isolates.</p>
<fig id="pbio.3000304.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000304.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Some primate species encode a CD4 that functions as an entry receptor for an early isolate of HIV-1.</title>
<p>(A) Cryo-EM structure of the Envelope (Env) trimer (blue) from a prototypic early HIV-1 isolate (BG505 [<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>]) in complex with human CD4 (tan) (PDB:5U1F) [<xref ref-type="bibr" rid="pbio.3000304.ref028">28</xref>]. Only the D1 and D2 domains of CD4 are included in this structure, and the D1 domain mediates interaction with Env. Amino acids highlighted in red spheres were previously shown to be evolving under recurrent positive selection and fall at the interaction interface with Env [<xref ref-type="bibr" rid="pbio.3000304.ref020">20</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref021">21</xref>]. (B) Dog thymocytes (Cf2Th cells) stably expressing human CCR5 and the indicated CD4 receptors (x-axis) were infected with Q23ΔEnv-GFP pseudotyped with BG505 Env, isolated from a newly infected infant [<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>]. The percent cells infected (GFP-positive) was enumerated by flow cytometry and normalized to the percent infected with human CD4. Error bars represent the mean + SEM from four independent experiments, each with two to three technical replicates. Values above error bars represent fold decrease in viral entry relative to human CD4, only indicated for those samples that passed significance thresholds (one-way ANOVA for repeated measures effect, Dunnett’s test; <italic>P</italic> &lt; 0.05). Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s005">S1 Data</xref>). (Top) Cladogram of species used in this experiment, with the number of amino acid differences in the D1 domain of CD4 (compared to human CD4) noted at the branch tips as well as the amino acid encoded at position 39. CCR5, C-C motif chemokine receptor 5; cryo-EM, cryogenic electron microscopy; GFP, green fluorescent protein; PDB, Protein Data Bank.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.g001" xlink:type="simple"/>
</fig>
<p>Here, we evaluate the ability of primate CD4 proteins to function as receptors for various classes of HIV-1. We are particularly interested in primary HIV-1 isolates derived from the blood of newly infected people, in light of the new appreciation for the special properties that relate to transmission [<xref ref-type="bibr" rid="pbio.3000304.ref029">29</xref>]. One primate genus (macaques; both rhesus and pig-tailed species) has previously been evaluated for the ability of its CD4 receptor to support entry of early HIV-1 isolates. Unfortunately, the macaque CD4 receptor does not support entry of the vast majority of early HIV-1 isolates, frustrating attempts to model transmission and early HIV-1 infection in these animals [<xref ref-type="bibr" rid="pbio.3000304.ref030">30</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref032">32</xref>]. On the other hand, we found that most allelic forms of owl monkey CD4 do support entry of early HIV-1 isolates [<xref ref-type="bibr" rid="pbio.3000304.ref033">33</xref>]. Beyond these species, the compatibility of early HIV-1 isolates with primate CD4 receptors has not been explored. We reasoned that HIV-1 compatibility with primate CD4 receptors might be dynamic, given that CD4 is highly diverged in its protein sequence at the interaction interface with HIV-1 Env (<xref ref-type="fig" rid="pbio.3000304.g001">Fig 1A</xref>).</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Primate CD4 receptors are functionally diverse in supporting HIV-1 entry</title>
<p>We began by cloning the CD4 genes of 15 primate species, plus human CD4. Using retroviral transduction, we stably introduced these genes into Cf2Th cells (dog thymocytes) that had also been engineered to express the human C-C motif chemokine receptor 5 (CCR5) coreceptor for HIV-1 entry (<xref ref-type="supplementary-material" rid="pbio.3000304.s001">S1 Fig</xref>). Expression levels of these CD4 receptors on Cf2Th cells were similar to endogenous expression levels of CD4 seen on human immortalized T cells and on primate primary T cells that we isolated directly from blood (<xref ref-type="supplementary-material" rid="pbio.3000304.s001">S1 Fig</xref>). Our goal was then to infect these cells with an early HIV-1 isolate. For the sake of this study, we refer to all viruses or Env clones that were isolated &lt;150 days post infection as “early” and those isolated &gt;150 days post infection as “chronic” isolates. This nomenclature is consistent with the Fiebig scale classification, for which Fiebig stages I–V (typically lasting until 70 to 150 days post infection) capture early infection stages and Fiebig stage VI indicates progression into chronic infection [<xref ref-type="bibr" rid="pbio.3000304.ref034">34</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref035">35</xref>]. This is also consistent with other studies on transmitted or early HIV-1, which have used viruses isolated from human blood weeks to months after infection [<xref ref-type="bibr" rid="pbio.3000304.ref005">5</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref031">31</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref036">36</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref037">37</xref>]. The properties of all of the HIV-1 Env isolates used in this study are summarized in <xref ref-type="supplementary-material" rid="pbio.3000304.s004">S1 Table</xref>.</p>
<p>The HIV-1 Envelope clone “BG505” has risen to prominence in the study of early HIV-1. The Overbaugh group amplified BG505 Env from an infant approximately 6 weeks after delivery and showed that this Env sequence was nearly identical to the two other Env sequences amplified from this baby at the same time point [<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>]. This indicated that the infection probably started from a single virion and that the captured Env sequence closely resembles the Env of this transmitted virion. A cocrystal of BG505 Env has been solved in complex with CD4 (<xref ref-type="fig" rid="pbio.3000304.g001">Fig 1A</xref>) [<xref ref-type="bibr" rid="pbio.3000304.ref028">28</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref038">38</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref040">40</xref>], and the alternate folding conformations of BG505 Env have been characterized in depth [<xref ref-type="bibr" rid="pbio.3000304.ref041">41</xref>]. We prepared HIV-1 pseudotyped with the BG505 Env by cotransfecting 293T cells with two plasmids: one expressing the BG505 Env, and another expressing an HIV-1 green fluorescent protein (GFP) reporter virus genome (Q23ΔEnv-GFP, representing a blood-derived clade A isolate from 1 year after seroconversion [<xref ref-type="bibr" rid="pbio.3000304.ref030">30</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref042">42</xref>]). Cell lines expressing human CCR5 and different primate CD4 receptors were then infected with this BG505 virus (similar infection results were obtained in cell lines expressing matched CD4 and CCR5 from each species; <xref ref-type="supplementary-material" rid="pbio.3000304.s002">S2 Fig</xref>). Forty-eight hours post infection, cells were harvested and analyzed by flow cytometry. Samples were first gated for live cells and further gated such that all samples were narrowed to the same log decade of CD4 receptor expression (<xref ref-type="supplementary-material" rid="pbio.3000304.s001">S1 Fig</xref>). GFP-positive (i.e., infected) cells were then enumerated within this population. We identified three categories of CD4 receptors that support HIV-1 entry to varying degrees (<xref ref-type="fig" rid="pbio.3000304.g001">Fig 1B</xref>). The CD4 receptors of some species (shown with purple bars: white-cheeked gibbon, olive baboon, gelada, black snub-nosed monkey, colobus, and owl monkey) behave similarly to human CD4 when challenged with BG505 HIV-1. These species are not our closest relatives but rather are distributed throughout the primate phylogeny (<xref ref-type="fig" rid="pbio.3000304.g001">Fig 1B</xref>). A second class of species (shown with gray bars: chimpanzee, gorilla, orangutan, and sooty mangabey) encodes CD4 receptors that support entry of this virus but at a level that is approximately 2-fold lower than human CD4. A third class of species (macaques, mandrills, sabaeus monkeys, and squirrel monkeys) encodes CD4 receptors that support entry at a level 25-fold or more reduced compared to human CD4. With some of the CD4 receptors in the latter class, infection was reduced by more than 100-fold compared to human CD4. While the chimpanzee CD4 allele tested here has a semi-permissive phenotype, we have recently shown that some chimpanzee CD4 alleles are highly resistant to HIV-1 entry [<xref ref-type="bibr" rid="pbio.3000304.ref048">48</xref>]. As a control, we determined that infection did not change the surface expression level of human or any primate CD4 receptor (<xref ref-type="supplementary-material" rid="pbio.3000304.s001">S1 Fig</xref>). This allows us to conclude that the observed differences in infection are due to defects in entry and that our gating strategy did not exclude infected cells because they no longer express CD4. From this data, we can conclude that CD4 receptors are functionally variable from one primate species to the next with regards to supporting entry of an early HIV-1 isolate. Prior to this, there was only one primate species known to encode a CD4 receptor compatible with early HIV-1 isolates, owl monkeys [<xref ref-type="bibr" rid="pbio.3000304.ref033">33</xref>], but now we can add five additional species to that list: white-cheeked gibbon, olive baboon, gelada, black snub-nosed monkey, and colobus monkey.</p>
<p>HIV-1 entry requires engagement of the amino-terminal “D1” domain of the CD4 receptor (residues 1–98). This is evidenced by numerous Env–CD4 cocrystals [<xref ref-type="bibr" rid="pbio.3000304.ref043">43</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref045">45</xref>] and mapping of D1-domain residues that affect interaction with HIV-1 Env [<xref ref-type="bibr" rid="pbio.3000304.ref043">43</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref046">46</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref048">48</xref>]. For instance, the macaque CD4 receptor can be rendered functional for HIV-1 entry by introducing a single amino acid substitution in the D1 domain (isoleucine “39I” mutated to the human residue, asparagine “39N”) [<xref ref-type="bibr" rid="pbio.3000304.ref031">31</xref>]. Likewise, owl monkey populations circulate CD4 alleles that are both non-functional (39I) and functional (39N) for HIV-1 entry [<xref ref-type="bibr" rid="pbio.3000304.ref033">33</xref>]. From the panel of primate CD4s that we have tested, we can now build on this observation that residue 39 in CD4 is particularly important for HIV-1 engagement. In <xref ref-type="fig" rid="pbio.3000304.g001">Fig 1B</xref>, the residues encoded at CD4 position 39 in each species are listed at the tips of the phylogeny, along with the total number of amino acid differences in the D1 domain compared to human CD4. From this, it appears that CD4 must encode an asparagine (“N”) at position 39 in order to have any appreciable function as a receptor for BG505 HIV-1. Indeed, position 39 in CD4 has experienced positive selection during primate speciation [<xref ref-type="bibr" rid="pbio.3000304.ref020">20</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref021">21</xref>], and this may be because mutations that replace the asparagine protect individuals against infection. However, there are clearly sequence determinants outside of position 39 that also matter because not all receptors with an asparagine at position 39 function equally well.</p>
</sec>
<sec id="sec004">
<title>The selective use of primate CD4 receptors is a property of HIV-1 from the bloodstream, including early HIV-1 isolates</title>
<p>We next sought to determine whether the selective use of only some primate CD4 receptors is a property specific to early HIV-1 isolates. From this point forward, we focused on CD4 receptors from a subset of primate species, in particular the African primate species involved in the zoonotic transmissions of HIV-1 (chimpanzees and gorillas) and HIV-2 (sooty mangabeys) [<xref ref-type="bibr" rid="pbio.3000304.ref017">17</xref>], and the macaque species that serve as the current laboratory model for HIV-1 (expression histograms for these cell lines are shown in <xref ref-type="supplementary-material" rid="pbio.3000304.s002">S2 Fig</xref>). All of these receptors were partially or highly defective for entry mediated by BG505 Env (<xref ref-type="fig" rid="pbio.3000304.g001">Fig 1B</xref>). We next tested Envs isolated from the blood of four individuals chronically infected with HIV-1 at time points more than 6 months after the original infection [<xref ref-type="bibr" rid="pbio.3000304.ref049">49</xref>]. These Envs were pseudotyped onto Q23ΔEnv-GFP, as described above. These viruses were then used to infect stable cell lines expressing human CCR5 and CD4 from different primate species. Two of the four Envs demonstrated the specific use of human CD4 that we have described (<xref ref-type="fig" rid="pbio.3000304.g002">Fig 2A</xref>, left two panels). The other two demonstrated a weakening of this selective CD4 phenotype but still a preference for human CD4 (<xref ref-type="fig" rid="pbio.3000304.g002">Fig 2A</xref>, right two panels). This suggests that the phenotype of selective CD4 usage may be retained during later stages of disease and may not be unique to early HIV-1 isolates.</p>
<fig id="pbio.3000304.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000304.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Selective use of primate CD4 receptors is not a result of the transmission bottleneck and instead is seen in many isolates of HIV-1 taken from human blood.</title>
<p>Cells stably expressing human CCR5 and human or primate CD4 (x-axis) were infected with Q23ΔEnv-GFP bearing (A) chronic Envelopes (Envs) [<xref ref-type="bibr" rid="pbio.3000304.ref049">49</xref>], (B) early (newly infected; grey bars) and chronic (6 months post infection; black bars) Env pairs derived from the same patient [<xref ref-type="bibr" rid="pbio.3000304.ref003">3</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref014">14</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref050">50</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref051">51</xref>], shown for one patient in each panel, or (C) Envs derived from maternal (chronic; black bars)/infant (newly infected; grey bars) transmission pairs [<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>], with one mother–baby pair shown in each panel. The percent cells infected (GFP-positive) was measured by flow cytometry and normalized to the percent infected with human CD4. Error bars represent the mean + SEM from two independent experiments, each with two to three technical replicates. Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s006">S2 Data</xref>). CCR5, C-C motif chemokine receptor 5; GFP, green fluorescent protein.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.g002" xlink:type="simple"/>
</fig>
<p>To address this further, we looked at how CD4 receptor usage may change over time as infection progresses from early- to late-stages of disease. To test this, we made use of sets of molecular clones that had been amplified by single-genome amplification from patient blood early after infection and then again from the same patient 6 months later [<xref ref-type="bibr" rid="pbio.3000304.ref003">3</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref014">14</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref050">50</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref051">51</xref>]. From four such sets of molecular clones, we cloned the rev-env cassettes into a mammalian expression vector, which was then used to pseudotype each Env onto Q23ΔEnv-GFP, as described above. These viruses were tested for their ability to enter cell lines stably expressing human or primate CD4 receptors, along with human CCR5. We observed no significant difference in receptor usage between the early Env (grey bars) and its matched 6-month counterpart (black bars) (<xref ref-type="fig" rid="pbio.3000304.g002">Fig 2B</xref>). In fact, for each patient, the Envs derived from the two different time points (6 months apart) behaved almost identically. Infection mediated by all of these Envs was reduced in cells expressing chimpanzee or macaque CD4 receptors when compared to human CD4. One exception was seen with virus from patient CH40, whose Env did mediate entry somewhat better via chimpanzee and macaque CD4 compared to other Envs, although still less well than with human CD4. Therefore, selective use of primate CD4 receptors appears to describe many HIV-1 isolates from the blood, including those isolated just after infection (weeks), later at 6 months (<xref ref-type="fig" rid="pbio.3000304.g002">Fig 2B</xref>), or even during chronic stages of infection (<xref ref-type="fig" rid="pbio.3000304.g002">Fig 2A</xref>).</p>
<p>We next examined the transmission bottleneck directly by testing matched donor–recipient HIV-1 Env pairs. HIV-1 was pseudotyped with Envs from mother–infant pairs, of which the mother was chronically infected and her baby was newly infected (&lt;6 weeks) [<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>]. For seven such pairs, we found that mother HIV-1 Envs (black bars) were not different from infant HIV-1 Envs (grey bars), in that all demonstrated the selective use of human CD4 (<xref ref-type="fig" rid="pbio.3000304.g002">Fig 2C</xref>). In fact, corresponding mother and baby Envs behaved very similarly. When the seven pairs were grouped, no significant differences were noted between maternal (chronic) and infant (early) Envs in terms of their ability to infect cells bearing chimpanzee or rhesus macaque CD4 receptors (Mann–Whitney test, <italic>P</italic> &gt; 0.05). The tested pairs represented most major HIV-1 group M subtypes, suggesting that selective use of CD4 may describe all or most globally circulating forms of HIV-1. We next verified this by challenging cell lines expressing different CD4 receptors with early HIV-1 isolates representing each of the four major group M (pandemic) HIV-1 subtypes. These four Envs, isolated from patient blood shortly after initial infection [<xref ref-type="bibr" rid="pbio.3000304.ref036">36</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref052">52</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref053">53</xref>], were pseudotyped onto the Q23ΔEnv-GFP virus, as described before. While human CD4 supported entry of all of these viruses, primate CD4 orthologs supported levels of HIV-1 entry that ranged from 2- to 58-fold lower (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3A</xref>). Collectively, our study has explored a breadth of HIV-1 isolates taken from patient blood, representing all of the major subtypes found globally, and has found that they can all be phenotypically described by their selective use of only certain primate CD4 receptors.</p>
<fig id="pbio.3000304.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000304.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Macrophage-tropic HIV-1 isolates, which are known to bind human CD4 more tightly, are promiscuous in their use of primate CD4 receptors.</title>
<p>(A, B) Cells stably expressing various primate CD4 receptors (x-axis), along with human CCR5, were infected with Q23ΔEnv-GFP pseudotyped with (A) early HIV-1 Envelopes (Envs) or (B) Envs from common macrophage-tropic HIV-1 isolates. The percent cells infected (GFP-positive) was measured by flow cytometry and normalized to the percent infected with human CD4. Error bars represent the mean + SEM from two independent experiments, each with two to three technical replicates. Values above error bars represent fold decrease in viral entry relative to human CD4, only indicated for those samples that passed significance thresholds (one-way ANOVA for repeated measures effect, Dunnett’s test; <italic>P</italic> &lt; 0.05). (C and D) Infection of TZM-bl cells with Q23ΔEnv-GFP pseudotyped with early (C) or macrophage-tropic (D) Envs. Each virus was preincubated with increasing concentrations of human soluble CD4 (sCD4) as a competitive inhibitor. TZM-bl cells are HeLa CD4/CCR5 cells that express luciferase in response to HIV-1 tat expression, read in relative light units (RLUs). Error bars represent the mean + SD from one biological replicate (<italic>n</italic> = 3 to 4 technical replicates), representative of two independent experiments. Error bars are not plotted in instances in which the size of the error bar is less than the symbol size. IC<sub>50</sub> values from the soluble CD4 neutralization assays are shown within each panel, for which the mean and SD values reflect the variation of the IC<sub>50</sub> calculations from two independent experiments. (E and F) Same as C and D, only neutralization assays were performed with chimpanzee and rhesus macaque sCD4 instead of human sCD4. Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s007">S3 Data</xref>). CCR5, C-C motif chemokine receptor 5; GFP, green fluorescent protein.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec005">
<title>Selective use of only certain primate CD4 receptors results from weak CD4 binding affinity</title>
<p>Next, we wanted to understand more about why blood-derived HIV-1 Env isolates demonstrate this selective use of only some primate CD4 receptors. Thus far, all of the Envs that we have tested are from CCR5-tropic viruses isolated from the blood. There are three types of HIV-1 in the body of an infected person: CCR5 T cell-tropic (the most abundant form in the blood, utilizing the CCR5 coreceptor), CXCR4 T cell-tropic (in the blood but using an alternate coreceptor, C-X-C chemokine receptor type 4 [CXCR4]), and CCR5 macrophage-tropic (rare in the blood, usually found in the central nervous system) [<xref ref-type="bibr" rid="pbio.3000304.ref029">29</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref054">54</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref056">56</xref>]. Only the first of these transmits to new individuals, whereas the latter two types arise in special evolutionary niches within the human body during the course of chronic infection and rarely transmit [<xref ref-type="bibr" rid="pbio.3000304.ref057">57</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref063">63</xref>]. In this study, we did not consider or test CXCR4-utilizing viruses. We next tested HIV-1 pseudotyped with Envs from four macrophage-tropic viruses [<xref ref-type="bibr" rid="pbio.3000304.ref031">31</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref064">64</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref072">72</xref>] for their ability to infect cells bearing primate CD4 receptors (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3B</xref>). In stark contrast to the blood-derived isolates tested above (Figs <xref ref-type="fig" rid="pbio.3000304.g001">1</xref>, <xref ref-type="fig" rid="pbio.3000304.g002">2</xref> and <xref ref-type="fig" rid="pbio.3000304.g003">3A</xref>), macrophage-tropic viruses were promiscuous in their use of all CD4 receptors tested. For each primate CD4 tested, the median relative infection for all early HIV-1 Envs (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3A</xref>) was significantly lower than macrophage-tropic Envs (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3B</xref>; <italic>P</italic> &lt; 0.05; Mann–Whitney U test).</p>
<p>Macrophage-tropic HIV-1 Env is known to bind CD4 with higher affinity compared to other forms of HIV-1 Env [<xref ref-type="bibr" rid="pbio.3000304.ref073">73</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref075">75</xref>]. This is a selected property that these virions possess because macrophages have lower densities of CD4 molecules on their surface [<xref ref-type="bibr" rid="pbio.3000304.ref074">74</xref>]. Based on this, we hypothesized that weak CD4 binding affinity is what makes most blood-derived HIV-1 Envs sensitive to small sequence differences in CD4 receptors from different primates. To test this, we first purified a soluble version of the human CD4 receptor for use in neutralization assays (sCD4, consisting of the D1 and D2 domains of CD4) (<xref ref-type="supplementary-material" rid="pbio.3000304.s003">S3 Fig</xref>). When sCD4 is preincubated with HIV-1, it is known to competitively inhibit virus interaction with the CD4 expressed on the cell surface and block virus entry [<xref ref-type="bibr" rid="pbio.3000304.ref076">76</xref>]. Our purified human sCD4 behaved identically to a commercially available version (<xref ref-type="supplementary-material" rid="pbio.3000304.s003">S3 Fig</xref>). HIV-1 pseudotyped with early or macrophage-tropic Envs was preincubated with increasing concentrations of sCD4 and then used to infect TZM-bl indicator cells (HeLa CD4/CCR5 cells that express luciferase in response to HIV-1 tat expression). HIV-1 pseudotyped with either of two different early Envs (BG505 or AC10.0.29) was neutralized in a dose-dependent manner by human sCD4 (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3C</xref>). As expected, HIV-1 pseudotyped with either of two macrophage-tropic Envs (BaL or SF162) was neutralized by human sCD4 to an even greater extent, consistent with these viruses having a higher affinity for CD4 (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3D</xref>). The IC<sub>50</sub> values are shown within each panel and are approximately 4-fold higher for early Envs than for macrophage-tropic Envs. In conclusion, the broadened ability to enter cells through the CD4 receptors encoded by all primates tested (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3A and 3B</xref>) correlates with tighter CD4 binding (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3C and 3D</xref>).</p>
<p>We next wanted to confirm that weak binding to human CD4 receptors results in a loss of binding to primate CD4 receptors. We purified chimpanzee and rhesus macaque sCD4 (<xref ref-type="supplementary-material" rid="pbio.3000304.s003">S3 Fig</xref>) and tested the ability of these proteins to neutralize different classes of HIV-1. Viruses bearing macrophage-tropic Envs (BaL or SF162) were neutralized by chimpanzee and macaque sCD4 (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3F</xref>), while viruses bearing Envs from early HIV-1 isolates (BG505 or AC10.0.29) were not neutralized to an appreciable degree (<xref ref-type="fig" rid="pbio.3000304.g003">Fig 3E</xref>). Collectively, these data suggest that most early HIV-1 isolates from the blood, which have lower affinity for human CD4 compared to macrophage-tropic viruses, do not bind well to chimpanzee and macaque CD4. This shows that our entry assay for selective versus promiscuous use of primate CD4s is essentially a readout of CD4 binding affinity.</p>
<p>To further test this premise, we next created a panel of Envs engineered to have high, medium, or low binding affinity for CD4. BG505 Env, the prototypic early Env discussed above, was engineered to have two different point mutations, one at position 281 and the other at position 375. These mutations in Env have been previously shown to increase binding affinity to CD4, although only one of them has been characterized within the BG505 Env background [<xref ref-type="bibr" rid="pbio.3000304.ref077">77</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref078">78</xref>]. Consistent with these previous reports, the A281V mutation subtly increased binding to human sCD4 relative to wild type (demonstrated by increased neutralization by sCD4), while the S375Y mutation resulted in a more substantial increase (<xref ref-type="fig" rid="pbio.3000304.g004">Fig 4A</xref>). While both of these mutations were originally characterized because they increase entry via macaque CD4 [<xref ref-type="bibr" rid="pbio.3000304.ref077">77</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref078">78</xref>], we found that both mutations also improve entry via all of the primate CD4 receptors tested, with increasing improvement as the binding affinity for CD4 increases (left to right in <xref ref-type="fig" rid="pbio.3000304.g004">Fig 4B</xref>). This pattern of increased binding affinity for human CD4 and increased ability to enter cells via primate CD4s also correlated to increased binding affinity for primate CD4 receptors, as read in a neutralization assay with purified chimpanzee and rhesus macaque sCD4 proteins (left to right in <xref ref-type="fig" rid="pbio.3000304.g004">Fig 4C</xref>). Finally, we engineered two additional mutations into HIV-1 BG505 Env that have been shown to increase CD4 binding and to increase entry via macaque CD4 [<xref ref-type="bibr" rid="pbio.3000304.ref077">77</xref>]. These mutations also make Env able to more efficiently mediate entry via all primate CD4s tested, not just that of macaques (<xref ref-type="fig" rid="pbio.3000304.g004">Fig 4D</xref>). These data support the general premise that promiscuous use of primate CD4s can be created by mutations in Env that increase CD4 binding affinity. Further, the promiscuous use of primate CD4 receptors is not just a property of macrophage-tropic viruses but instead may be a common property of viruses engineered or adapted to bind CD4 more tightly. The fact that virtually no blood-derived HIV-1 isolate that we have tested has this phenotype (promiscuous use of primate CD4 receptors) suggests that this phenotype is strongly selected against in the human body. The reasons for this are unknown.</p>
<fig id="pbio.3000304.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000304.g004</object-id>
<label>Fig 4</label>
<caption>
<title>An early Env engineered to have weak, medium, or tight binding to CD4 becomes progressively more promiscuous in its use of primate CD4 receptors.</title>
<p>(A–C) Amino acid substitutions were introduced into the BG505 Envelope (Env) at position 281 and 375. The headers at the top describing these mutations pertain to panels A, B, and C. In each column, the indicted Env was pseudotyped onto Q23ΔEnv-GFP. (A) Each of the three viruses was preincubated with increasing concentrations of human soluble CD4 (sCD4) and then used to infect TZM-bl cells, which are HeLa CD4/CCR5 cells that express luciferase in response to HIV-1 infection and tat expression, read in relative light units (RLUs). Error bars represent the mean + SD from one biological replicate, representative of two independent experiments. Error bars are not plotted in instances in which the size of the error bar is less than the symbol size. IC<sub>50</sub> values are listed on each panel, for which the mean and SD values reflect the variation of the IC<sub>50</sub> calculations from two independent experiments. (B) Cells stably expressing the indicated CD4s (x-axis) and human CCR5 were infected with each virus. The percent cells infected (GFP-positive) was measured by flow cytometry and normalized to the percent infected with human CD4. Error bars represent the mean + SEM from two independent experiments, each with three technical replicates. Values above error bars represent fold decrease relative to human CD4 for those samples that passed significance thresholds (one-way ANOVA for repeated measures effect, Dunnett’s test; <italic>P</italic> &lt; 0.05). (C) Same as panel A but with chimpanzee and rhesus macaque sCD4 instead of human sCD4. (D) Two additional single point mutations were introduced into the BG505 Env, which have also been shown to increase binding affinity for CD4 [<xref ref-type="bibr" rid="pbio.3000304.ref077">77</xref>]. These Envs were pseudotyped onto Q23ΔEnv-GFP and used to infect cells stably expressing the indicated CD4 (top of each graph) and human CCR5. The percent cells infected (GFP-positive) was measured by flow cytometry and normalized to the percent infected with human CD4. Error bars represent the mean + SEM from two independent experiments, each with two to three technical replicates. Values above error bars represent fold increase relative to wildtype BG505 Env for those samples that passed significance thresholds (one-way ANOVA for repeated measures effect, Dunnett’s test; <italic>P</italic> &lt; 0.01). Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s008">S4 Data</xref>). CCR5, C-C motif chemokine receptor 5; GFP, green fluorescent protein.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.g004" xlink:type="simple"/>
</fig>
<p>We then employed a virus-free approach to confirm that the mechanism of selective use of certain primate CD4 receptors stems from weak CD4 binding, as opposed to other interactions between HIV-1 and CD4 that may occur during the course of an infection. Cells expressing HIV-1 Env on their surface were mixed with cells expressing human CCR5 and various primate CD4 receptors (<xref ref-type="fig" rid="pbio.3000304.g005">Fig 5A</xref>). Cellular fusion was assessed using a split luciferase reporter system in which, upon cell–cell fusion, the two halves of luciferase merge and produce a functional enzyme [<xref ref-type="bibr" rid="pbio.3000304.ref079">79</xref>]. We used this assay to test the interactions between four different Envs and six different CD4 receptors, as shown in <xref ref-type="fig" rid="pbio.3000304.g005">Fig 5B</xref>. In this system, the phenotypes seen in our previous infection assays were largely recapitulated despite the fact that this assay is virus-free and only requires three proteins (Env and CD4/CCR5). The early Envs mediated fusion most efficiently with cells expressing human CD4, while the macrophage-tropic Envs broadly engaged and fused with diverse primate CD4 receptors. This assay, when taken together with the experiments employing purified CD4 described above, reveal that weak binding to CD4 is what makes most blood-derived HIV-1 isolates (i.e., those fueling the global pandemic) selective in their use of only certain primate CD4 receptors.</p>
<fig id="pbio.3000304.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000304.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Early isolates of HIV-1 from the blood are deficient in binding and/or fusion with CD4 from some primate species.</title>
<p>(A) 293T cells transiently expressing various Envelope proteins (Envs), and dog thymocytes (Cf2Th cells) stably expressing various primate CD4 receptors and human CCR5, were each transfected with plasmids encoding half of a split Renilla luciferase [<xref ref-type="bibr" rid="pbio.3000304.ref079">79</xref>]. These two cell types were then cocultured to induce membrane fusion, which was detected by a luminescent product following the addition of the Renilla luciferase substrate. (B) The percentage of fusion was calculated relative to what was observed with human CD4. Error bars represent the mean + SEM from three to four independent experiments, each with four technical replicates. Values above error bars represent fold decrease relative to human CD4 for those samples that passed significance thresholds (one-way ANOVA for repeated measures effect, Dunnett’s test; <italic>P</italic> &lt; 0.05). Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s009">S5 Data</xref>). CCR5, C-C motif chemokine receptor 5.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec006">
<title>Early HIV-1 isolates are blocked from entry by multiple allelic versions of macaque CD4</title>
<p>Interestingly, macaques (both rhesus and pig-tailed) encode a CD4 receptor that is not permissive for entry of most blood-derived HIV-1 isolates (Figs <xref ref-type="fig" rid="pbio.3000304.g001">1</xref>, <xref ref-type="fig" rid="pbio.3000304.g002">2</xref>, <xref ref-type="fig" rid="pbio.3000304.g003">3</xref> and <xref ref-type="fig" rid="pbio.3000304.g004">4</xref>), consistent with previous reports [<xref ref-type="bibr" rid="pbio.3000304.ref030">30</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref077">77</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref078">78</xref>]. Since macaques (predominantly rhesus macaques) serve as the current animal model for HIV-1, we sought to determine whether some allelic variants of rhesus macaque CD4 might encode receptors that better support HIV-1 infection. We sequenced the CD4 gene from 52 captive Indian-origin rhesus macaques and identified alleles encoding five unique CD4 protein variants (<xref ref-type="fig" rid="pbio.3000304.g006">Fig 6A</xref>). All of these allelic versions of rhesus macaque CD4 behaved identically and were nonfunctional for entry of virus pseudotyped with BG505 Env and also with Env from another early HIV-1 isolate, CAP210.2.00.E8 (<xref ref-type="fig" rid="pbio.3000304.g006">Fig 6B</xref>). Therefore, while owl monkey and chimpanzee populations circulate CD4 alleles with dramatically different functions as receptors for HIV/SIV entry [<xref ref-type="bibr" rid="pbio.3000304.ref033">33</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref048">48</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref080">80</xref>], it appears that the function of macaque CD4 is identical from one allele to the next.</p>
<fig id="pbio.3000304.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000304.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Rhesus macaque CD4 alleles are universally defective for HIV-1 entry.</title>
<p>(A) Total RNA was isolated from the blood of 52 rhesus macaque individuals. CD4 was amplified from cDNA, and PCR products were sequenced to yield genotype information for each individual (104 chromosomes). Genotype information was used to phase SNPs using Phase 2.1 [<xref ref-type="bibr" rid="pbio.3000304.ref081">81</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref082">82</xref>] in DNAsp v5 [<xref ref-type="bibr" rid="pbio.3000304.ref083">83</xref>]. The table summarizes the unique CD4 alleles identified. For each allele, the residue encoded at each variable amino acid positions is noted. Unique alleles were cloned and further verified by Sanger sequencing. (B) Dog thymocytes (Cf2Th cells) stably expressing human CCR5 and the indicated rhesus macaque CD4 alleles (x-axis) were infected with HIV-1 (Q23ΔEnv-GFP) bearing a subtype A (BG505) or subtype C (CAP210.2.00.E8) Envelope (Env). The percent cells infected (GFP-positive) was measured by flow cytometry 48 hours post infection. Error bars represent the mean + SEM from two independent experiments, each with three technical replicates. Values above error bars represent fold decrease relative to human CD4 for those samples that passed significance thresholds (one-way ANOVA for repeated measures effect, Dunnett’s test; <italic>P</italic> &lt; 0.05). (C) 293T cells transiently expressing diverse HIV-1 Envs (see <xref ref-type="supplementary-material" rid="pbio.3000304.s004">S1 Table</xref>) and Cf2Th cells stably expressing the indicated CD4/CCR5 receptors were each transfected with plasmids encoding half of a split Renilla luciferase [<xref ref-type="bibr" rid="pbio.3000304.ref079">79</xref>]. These two cell types were then cocultured to induce membrane fusion, which was detected by a luminescent product following the addition of the renilla luciferase substrate. A total of 33 Envs were tested from the following major HIV-1 subtypes: subtype A (<italic>n</italic> = 12), subtype B (n = 7), subtype C (<italic>n</italic> = 6), subtype D (<italic>n</italic> = 6), and subtype A/D (<italic>n</italic> = 2). The percentage of fusion was calculated relative to what was observed with human CD4/CCR5. Error bars represent the mean + SD, for which <italic>n</italic> = 2 (two technical replicates from one experiment). Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s010">S6 Data</xref>). nt, nucleotide; aa, amino acid; CCR5, C-C motif chemokine receptor 5; GFP, green fluorescent protein.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.g006" xlink:type="simple"/>
</fig>
<p>In this study, we have shown that Envs from over 30 early and chronic HIV-1 isolates from human blood (mother–infant pairs, etc.) all demonstrate selective entry via only some primate CD4 receptors. We next tested 29 additional Envs (<italic>n</italic> = 33 total, four of which were previously tested in infection assays herein; <xref ref-type="supplementary-material" rid="pbio.3000304.s004">S1 Table</xref>) using the cell–cell fusion assay described above. These Envs were universally poor at mediating fusion with cells expressing rhesus macaque CD4 and CCR5 proteins (<xref ref-type="fig" rid="pbio.3000304.g006">Fig 6C</xref>). Similar data have been generated in other large screens of early HIV-1 Envs [<xref ref-type="bibr" rid="pbio.3000304.ref031">31</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref032">32</xref>]. Collectively, it seems that virtually no HIV-1 isolated from the bloodstream is compatible with the macaque version of CD4. If we now understand the inability of HIV-1 to use macaque CD4 to be a reflection of weak CD4 binding, this leads us to understand that virtually all early- and late-stage HIV-1 isolates in the human bloodstream experience continual selection to retain weak CD4 binding.</p>
</sec>
</sec>
<sec id="sec007" sec-type="conclusions">
<title>Discussion</title>
<p>We find that many HIV-1 isolates from the blood, including early HIV-1 isolates, enter cells poorly through a subset of primate CD4 receptors. This finding is highly analogous to what has been observed with primate restriction factors that block HIV-1 infection, in that they too are highly species-specific in their interaction with HIV-1 [<xref ref-type="bibr" rid="pbio.3000304.ref084">84</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref085">85</xref>]. Like CD4, most restriction factors are also evolving under intense positive selection in primates [<xref ref-type="bibr" rid="pbio.3000304.ref086">86</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref089">89</xref>], explaining why these proteins vary in protein sequence on virus-binding surfaces from one host species to the next. It appears that SIVs, and probably other viruses as well, have put intense selective pressure on these genes to evolve in a way that changes the protein sequence on virus-binding surfaces. The selection and retention of new CD4 alleles that block virus entry could protect a species from infection, at least until the virus population counter adapts. When this type of arms race is playing out in multiple host species independently, it drives divergence in protein sequence at host–virus binding interfaces and has the long-term effect of making it difficult for viruses to move between species [<xref ref-type="bibr" rid="pbio.3000304.ref016">16</xref>]. Indeed, a prevailing theme that has emerged in recent years is that receptor sequence divergence serves as a potent barrier to the movement of viruses between species [<xref ref-type="bibr" rid="pbio.3000304.ref016">16</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref090">90</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref094">94</xref>]. Likewise, this study suggests that HIV-1 entry is blocked by the CD4 receptor of some primate species that it might encounter, whether that be in the wild or in the lab. On the other hand, we identify several primate species that encode CD4 receptors compatible with unmodified isolates of HIV-1 from the human bloodstream, including early isolates. These species could possibly be useful as animal models of HIV-1 transmission and infection, assuming that restriction factor blocks can be overcome in these species.</p>
<p>We show that selective use of only certain primate CD4 receptors occurs when HIV-1 Env has weak binding affinity for CD4. This weak affinity makes HIV-1 Env sensitive to sequence differences in the CD4 molecule. The strongest evidence in favor of this model is that viruses that have been selected or engineered to have tight CD4 binding affinity become agnostic to sequence differences in primate CD4 and can more efficiently enter cells using all CD4 orthologs that we have tested. While neutralization assays to assess the CD4 binding affinity of a given virus are laborious, our assay for selective or promiscuous primate receptor usage allowed us to screen a large number of HIV-1 isolates from human blood. Based on this, we show that weak CD4 binding is a nearly constant property of HIV-1 circulating in the human bloodstream, including but not specific to early-stage virions. This underscores the need to further understand the significance of CD4 binding affinity to HIV biology. While it has long been known that different HIV types have different affinities for CD4, the functional consequences of this are unclear. This is important to understand because weak CD4 binding seems to be selected for in the human bloodstream, yet some of our current primate models use Envs that are engineered for tight CD4 binding affinity so that they more efficiently engage the nonpermissive macaque CD4 receptor. For example, mutations at HIV-1 Env 375, when engineered into SHIVs, render virons compatible with macaque CD4 [<xref ref-type="bibr" rid="pbio.3000304.ref077">77</xref>]. However, mutations at this position do not emerge in vivo when HIV-1 Envs are adapting to macaque CD4, whereas mutations at Env 281 do [<xref ref-type="bibr" rid="pbio.3000304.ref078">78</xref>]. Based on our data, we can now speculate that Envs with high binding affinity to CD4 have a fitness penalty in vivo.</p>
<p>Given that nearly all HIV-1 in the human bloodstream seems to be selected to bind CD4 weakly, why would this be preferable? Although the reasons for this are currently unclear, there have been numerous speculations put forward [<xref ref-type="bibr" rid="pbio.3000304.ref029">29</xref>]. It is possible that more efficient use of CD4 requires changes in Env conformation that would increase susceptibility to antibody neutralization. Indeed, Arrildt and colleagues have shown that when compared to patient matched T-cell tropic isolates from the blood, macrophage-tropic isolates appear to be more sensitive to certain CD4 binding site antibodies [<xref ref-type="bibr" rid="pbio.3000304.ref095">95</xref>]. Thus, any conformational change that increases antibody neutralization sensitivity would likely be purged from the viral population. Alternatively, tighter CD4 binding is known to enhance HIV-1 tropism for cells of the monocyte–macrophage lineage [<xref ref-type="bibr" rid="pbio.3000304.ref073">73</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref095">95</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref096">96</xref>]. However, replication of HIV-1 in these cells appears to be slowed due to cell type–specific blocks, including the restriction factors SAMHD1 and APOBEC3A [<xref ref-type="bibr" rid="pbio.3000304.ref097">97</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref098">98</xref>], delayed reverse transcription and integration [<xref ref-type="bibr" rid="pbio.3000304.ref099">99</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref100">100</xref>], and transcriptional repression [<xref ref-type="bibr" rid="pbio.3000304.ref101">101</xref>]. These blocks to replication in macrophages may put high-affinity CD4 binders at an evolutionary disadvantage during early stages of infection. Finally, highly efficient macrophage infection may directly promote disease via inflammatory processes. HIV-1 infection of central nervous system macrophages coincides with severe inflammation and neuronal impairment [<xref ref-type="bibr" rid="pbio.3000304.ref102">102</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref105">105</xref>]. Additionally, respiratory and cardiac dysfunction during late-stage HIV-1 infection has been associated with chronic inflammation, of which macrophages may be playing a central role [<xref ref-type="bibr" rid="pbio.3000304.ref106">106</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref107">107</xref>]. Viral infection is a delicate balance between replicating efficiently enough to transmit, yet limiting disease to maintain the health of the host. Altering cellular tropism via high-affinity CD4 binding may be disadvantageous to the virus, disproportionately skewing infection toward a more diseased state.</p>
<p>Herein, as in many other studies, comparative genetics between humans and primates has revealed to us new lessons about HIV’s interaction with its host. This has been a tremendously powerful tool in the HIV field, having led to the original identification of, and mechanistic insights into, many of the host factors that control HIV-1 biology (for only a few examples, see [<xref ref-type="bibr" rid="pbio.3000304.ref086">86</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref108">108</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref112">112</xref>]). As primate research becomes more tenuous [<xref ref-type="bibr" rid="pbio.3000304.ref113">113</xref>], we need to keep in mind how powerful these comparative approaches have been in the study of HIV-1 and in the study of other viruses as well (for only a few examples, see [<xref ref-type="bibr" rid="pbio.3000304.ref114">114</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref117">117</xref>]).</p>
</sec>
<sec id="sec008" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec009">
<title>Cells</title>
<p>HEK 293T (ATCC CRL-11268), TZM-bl (NIH ARP # 8129), and canine thymocytes (Cf2Th) (ATCC CRL-1430) were cultured in Dulbecco’s modified Eagle medium (Invitrogen) with 10% FBS, 2 mM L-glutamine, and 1% Pen Strep (complete medium). All cells were maintained at 37°C and 5% CO<sub>2</sub>.</p>
</sec>
<sec id="sec010">
<title>Isolation of primate CD4+ T cells from whole blood</title>
<p>Whole blood from owl monkey (<italic>Aotus vociferans</italic>) or rhesus macaque (<italic>Macaca mulatta</italic>) donors was received in plastic BD Vacutainer Plus K2EDTA tubes (Cat#366643, lavender cap). The blood samples were obtained from animals housed at the Keeling Center for Comparative Medicine and Research (KCCMR) in Bastrop, TX. Blood was diluted in an equal volume of balanced salt solution (one part solution A [5.5 x 10<sup>−3</sup> M Anhydrous D-glucose, 5.0 x 10<sup>−5</sup> M CaCl<sub>2</sub>-2H<sub>2</sub>O, 9.8 x 10<sup>−4</sup> M MgCl<sub>2</sub>-6H<sub>2</sub>O, 5.4 x 10<sup>−3</sup> M KCl, 0.145 M TRIS] to nine parts solution B [0.145 M NaCl]). Then, diluted blood was separated in density gradient media (Ficoll-Pacque PLUS GE17-1440-02) by 400 x g centrifugation for 40 minutes. The peripheral blood mononuclear cell layer (i.e., PBMCs or buffy coat) was removed and washed twice in three volumes of balanced salt solution per sample. Each donors’ PBMCs were then immediately subjected to a CD4-positive selection kit (EasySep Human CD4 Positive Selection Kit II Cat #17852) to isolate CD4+ T cells. Rhesus macaque and owl monkey CD4+ T cells were then activated for three days in RPMI supplemented with 100 U IL2/ml (recombinant human-IL2; Sigma #11011456001) and 5 μg/ml or 0.5 μg/ml PHA-P (Sigma L1668), respectively. CD4+ T-cell cultures were subsequently maintained in RPMI + 100 U IL2/ml media.</p>
</sec>
<sec id="sec011">
<title>Detection of CD4 receptor expression on T cells by flow cytometry</title>
<p>CD4+ T cells isolated from rhesus macaque or owl monkey whole blood (as described above) or human T cells (Hut78 cells) were analyzed for CD4 expression by flow cytometry (Beckman Coulter CyAn ADP High-Performance Flow Cytometer). Cells were first incubated in Fc receptor (Cd16 monoclonal antibody (3G8), eBioscience Cat #16-0166-82) blocking buffer (PBS + 2% FCS + 1mM EDTA + 0.5% BSA) on ice for 1 hour. These cells were then fixed in 1% PFA and stained for cell surface expression of CD4 (BD CD4 mouse anti-human, APC, clone: L200). On the cytometer, only live cells were gated and histograms of CD4 expression determined by unstained and isotype (BD Mouse IgG<sub>1</sub>, Κ, Cat #555751) controls.</p>
</sec>
<sec id="sec012">
<title>Envelope clones and mutagenesis</title>
<p>The following Env clones were obtained from the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: Env clones from early infection (QF495.23M.Env.A1 #11890 and QB857.23I.Env.B3 #11915 [<xref ref-type="bibr" rid="pbio.3000304.ref052">52</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref118">118</xref>] [Dr. Julie Overbaugh], AC10.0.29 #11024 [<xref ref-type="bibr" rid="pbio.3000304.ref053">53</xref>] [Drs. David Montefiori and Dr. Feng Gao], CAP210.2.00.E8 #11317 [<xref ref-type="bibr" rid="pbio.3000304.ref036">36</xref>] [Drs. L. Morris, K. Mlisana, and D. Montefiori]), chronic/lab-adapted Env clones commonly used in SHIVs (SF162 #10463 [<xref ref-type="bibr" rid="pbio.3000304.ref064">64</xref>–<xref ref-type="bibr" rid="pbio.3000304.ref066">66</xref>] [Drs. L. Stamatatos and C. Cheng-Mayer], BaL.26 #11446 [<xref ref-type="bibr" rid="pbio.3000304.ref069">69</xref>] [Dr. Mascola], and 89.6 #12485 [<xref ref-type="bibr" rid="pbio.3000304.ref071">71</xref>] [Drs. Kathleen Collins and Ronald Collman]), Env clones from chronic infections #12670 (CNE55, CH119, CNE8, X1632 #12670 [<xref ref-type="bibr" rid="pbio.3000304.ref049">49</xref>] [Dr. David Montefiori]), and Env clones from maternal and infant/baby transmission pairs #11674 (M/B535, M/BG505, M/BJ613, M/BL274, M/BK184, M/BJ412, M/BI206 [<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>] [Dr. Julie Overbaugh]). BG505.W6M.B1 [<xref ref-type="bibr" rid="pbio.3000304.ref009">9</xref>] and YU2 [<xref ref-type="bibr" rid="pbio.3000304.ref031">31</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref068">68</xref>] Envs were gifts from Dr. Julie Overbaugh. Single-genome amplification-derived molecular clones of T/F and 6-month chronic viruses (CH40, CH58, CH77, CH470 [<xref ref-type="bibr" rid="pbio.3000304.ref003">3</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref014">14</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref050">50</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref051">51</xref>]) were gifts from Dr. Beatrice Hahn. We amplified the Rev-Env cassettes from these by PCR, TA-cloned them into pCR8 (Clontech), and then used Gateway cloning to move them into a gateway converted pCDNA3.1 (Invitrogen) mammalian expression vector. Further description of these Env clones, and those used in the fusion assay screens, are described in <xref ref-type="supplementary-material" rid="pbio.3000304.s004">S1 Table</xref>. Nucleotide changes producing S375Y/W/H and A281V were introduced into BG505.W6M.B1 by site directed mutagenesis using overlapping PCR primers containing the mutation of interest, following standard methods.</p>
</sec>
<sec id="sec013">
<title>Receptor expression constructs and generation of stable cell lines</title>
<p>CD4 and/or CCR5 was amplified from RNA isolated from the following sources: Jurkat T cells (human CD4, Genbank MK170450), immortalized B-lymphocytes (rhesus macaque CCR5, Genbank NM_001309402.1), whole blood (rhesus macaque CD4 alleles 1–5, Genbank MF632286-MF632290; owl monkey CD4, Genbank MK205145), and fibroblasts (gorilla CD4, Genbank MK170451). Pig-tailed macaque CD4 and CCR5 were subcloned into the pCR8/GW/TOPO TA plasmid from pBabe retroviral vectors provided by Dr. Julie Overbaugh [<xref ref-type="bibr" rid="pbio.3000304.ref030">30</xref>]. Human CCR5 was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH (Human CCR5 expression vector pcCCR5 #3325 from Dr. Nathaniel Landau) and subcloned into the pCR8/GW/TOPO TA plasmid. The remaining constructs were purchased as gene block fragments (IDT), PCR amplified (Phusion HiFi Master Mix; Thermo Fisher), and TA cloned into the pCR8/GW/TOPO TA plasmid (Thermo Fisher). The Genbank sequences used for gene block synthesis are as follows: chimpanzee CD4 (NM_001009043.1) and CCR5 (U89797.1), sooty mangabey CD4 (NM_001319342.1) and CCR5 (XM_012033360.1), gorilla CCR5 (AF177901.1), sabaeus CD4 (XM_007967415.1), gelada CD4 (XM_025401282.1), mandrill CD4 (XM_011982990.1), colobus CD4 (XM_011952099.1), baboon CD4 (XM_003905871.3), black snub-nosed monkey CD4 (XM_017891844.1), white-cheeked gibbon CD4 (XM_004092147.1), squirrel monkey CD4 (AF452617.1), marmoset CD4 (AF452616.1), and orangutan CD4 (XM_024256502.1; incomplete CDS, missing 3′ sequence (15 nucleotides) was substituted with human CD4 residues). Following TA cloning, an LR Clonase II reaction (Invitrogen) was used to shuttle inserts into Gateway-converted pLPCX (CD4) or pLHCX (CCR5) retroviral packaging vectors (Clontech).</p>
<p>To produce retroviruses for transduction, HEK293T cells plated in antibiotic free media (1 x 10<sup>6</sup> cells/well in a 6-well plate) were transfected with a 2 μg of transfer vector (pLPCX [CD4] or pLHCX [CCR5] retroviral vector), 1 μg pCS2-mGP (MLV gag/pol), and 0.2 μg pC-VSVG (VSV-G envelope) using a 3:1 ratio of TransIT 293 (Mirus) transfection reagent to micrograms of DNA, according to manufacturer’s directions. Forty-eight hours post transfection, retrovirus VLPs were collected, filtered through 0.22-μm cellulose acetate filters, and stored at −80°C in single-use aliquots. Cf2Th cells were plated at 3 x 10<sup>4</sup> cells/well of a 12-well dish (approximately 15% confluent) and 24 hours later, transduced with 500 μl of retroviral supernatant by spinoculation at 1,200 x g for 75 minutes in the presence of 5 μg/ml polybrene. The following day, the cells were placed in complete medium containing antibiotic (3 μg/ml puromycin for pLPCX or 250 μg/ml hygromycin-B for pLHCX) and cultured until stable outgrowth was noted (&gt;1 week). Stable cell lines were maintained indefinitely in selection media.</p>
</sec>
<sec id="sec014">
<title>Single-cycle HIV-1 infections</title>
<p>To produce HIV-1 reporter viruses, 13 x 10<sup>6</sup> HEK293T cells were seeded into a 15-cm dish in antibiotic free media and 24 hours later transfected with 5.3 μg of Q23ΔEnv-GFP and 2.7 μg of Env plasmid. Q23ΔEnv-GFP, encoding an approximately 400-bp deletion in Env, and with GFP inserted into the <italic>nef</italic> gene (therefore destroying the function of <italic>nef</italic>), was obtained from Dr. Julie Overbaugh and described previously [<xref ref-type="bibr" rid="pbio.3000304.ref030">30</xref>]. Fourty-eight hours post transfection, the cell supernatant was harvested, concentrated (approximately 100-fold) using Amicon Ultracell 100K filters (Millipore), and stored at −80°C in single use aliquots. Virus titers were determined by FACS analysis for GFP-positive cells, using a range of virus dilutions on Cf2Th cells stably expressing human CD4 and CCR5. For infection assays, Cf2Th cells stably expressing CD4 and CCR5 were plated at 3 x 10<sup>4</sup> cells/well of a 48-well plate (approximately 60% confluent) 24 hours prior to infection. The cells were then infected with HIV-1 pseudoviruses at a multiplicity of infection (MOI) of approximately 0.6 in the presence of 5 μg/ml of polybrene by spinoculation at 1,200 x g for 75 minutes. Fourty-eight hours post infection, the cells were harvested from the plate and fixed in 2% paraformaldehyde for 10 minutes. The fixed cells were washed three times with PBS and resuspended in 50 μl FACS buffer (1X PBS buffer containing 2% FBS and 1 mM EDTA) antibody cocktail. All antibody pairs were used at 1:200 dilutions, and incubated at 4°C with cells for 30 minutes as follows: for primate CD4/primate CCR5 (<xref ref-type="supplementary-material" rid="pbio.3000304.s002">S2 Fig</xref>), PeCy7 mouse α-human CD4 clone L200 (BD #560644) and APC mouse α-human CD195 (CCR5) clone 3A9 (BD #560748); for all other studies, the combination of APC mouse α-human CD4 clone L200 (BD #551980) and PeCy7 mouse α-human CD195 (CCR5) 2D7 (BD #557752) was used. Stained cells were analyzed on a CyAn ADP (Beckman Coulter) flow cytometer. Following live-cell gating, CD4 and CCR5 expressing gates were drawn and then the percent GFP positive cells was enumerated within the double positive population. The data from approximately 1 x 10<sup>4</sup> live cells was analyzed using FlowJo version 10.</p>
</sec>
<sec id="sec015">
<title>Genotype and allele determination of Indian-origin macaque CD4</title>
<p>PAXgene (BD #762165) preserved whole blood was obtained from animals housed at the KCCMR per blood collection protocols approved by the University of Texas, MD Anderson Cancer Center IACUC. Total DNA/RNA was extracted using the AllPrep DNA/RNA mini kit (Qiagen). Extracted RNA was used as a template for oligo (dt) primed reverse transcription (SuperScript III RT; Thermo Fisher). PCR amplification of CD4 was performed using PCR Supermix HiFi (Thermo Fisher) containing 1–10 ng of cDNA and 0.2 μM final concentration of each PCR primer CD4-Forward 5′ AAGCAGCGGGCAAGAAAGACG 3′ and CD4-Reverse 5′ CAAGTTCCTGCCCTCTGTGG 3′ in a final volume of 25 μl. PCR cleanup was performed using Exonuclease-I and Shrimp Alkaline Phosphatase treatment (Affymetrix) for 15 minutes at 37°C, and then the cleaned-up products were Sanger sequenced using the following CD4-Forward 5′ GGAGTTCAAAATAGACATCG 3′ and CD4-Reverse 5′ CAGACACTTCCTTGTTCTTC 3′ sequencing primers. The resulting genotype information was used to phase SNPs using Phase 2.1 [<xref ref-type="bibr" rid="pbio.3000304.ref081">81</xref>,<xref ref-type="bibr" rid="pbio.3000304.ref082">82</xref>] in DNAsp v5 [<xref ref-type="bibr" rid="pbio.3000304.ref083">83</xref>]. Five unique rhesus macaque CD4 alleles were identified, TA cloned into the pCR8 gateway Topo TA cloning vector (Thermo Fisher), and then subcloned into the gateway converted pLPCX retroviral vector (Clontech). All constructs were further verified by Sanger sequencing. Allele 1 represented the major allele circulating in this population and was used in all experiments except where designated otherwise.</p>
</sec>
<sec id="sec016">
<title>Production of sCD4 and virus neutralization assays</title>
<p>Human, chimpanzee, and rhesus macaque CD4 cloned into the pCR8 plasmid (described above) served as a template for soluble CD4 (sCD4) PCR. The D1/D2 domain (nucleotide positions 75–603, minus signal peptide) was amplified by PCR and cloned into pHL-sec [<xref ref-type="bibr" rid="pbio.3000304.ref119">119</xref>] (Addgene #99845), which has been optimized for protein production in mammalian cells. 13 x 10<sup>6</sup> 293T cells (three 15-cm dishes) were transfected with 25 μg of sCD4 expression plasmids using TransIT-293 (Mirus), and cell supernatant containing secreted sCD4 was harvested at days three and six post transfection. Cell supernatant was spun down at 1,200 x g for 5 minutes to remove cell debris, filtered using a 0.45-μm cellulose acetate membrane, and mixed 1:1 with wash buffer (25 mM Na<sub>3</sub>PO<sub>4</sub> pH 7.4, 500 mM NaCl, 20 mM imidazole). Cleared cell supernatant was then incubated with 1-ml bed volume of Ni-NTA agarose beads (Qiagen, #30210) equilibrated in wash buffer for 2 hours at 4°C. The mixture was then added to a gravity flow chromatography column and the flow-through was passed through the column a second time. The Ni-NTA beads were washed with 50 ml of wash buffer. Bound protein was eluted with wash buffer containing 250 mM imidazole in 1-ml fractions. Fractions containing sCD4 were pooled, washed three times with PBS, and concentrated to 500 μl using an Amicon Ultra-15 ml centrifugal filter with a 10 kDa molecular weight cutoff (EMD Millipore, #UFC901008). The sample was purified to homogeneity on a Superdex 75 Increase 10/300 GL (GE Healthcare, #29-1487-21) in PBS. Purified samples were concentrated to 1 mg/ml using an Amicon Ultra 0.5-ml centrifugal filter with a 10-kDa molecular weight cutoff, aliquoted for single use, and flash-frozen in liquid nitrogen.</p>
<p>For the neutralization assays, each virus (normalized by equivalent TDU/ml) was incubated with serial 2-fold dilutions of sCD4 (range 30 μM to approximately 1 μM final concentration) at 37°C for 1 hour. Human, chimpanzee, and rhesus sCD4 were produced in this study (methods above), and commercially available human sCD4 was obtained through the National Institutes of Health AIDS Reagent Program: sCD4-183 #7356 (from Pharmacia, Inc.). Following incubation, the sCD4 treated and untreated viruses were spinoculated (1,200 x g for 75 minutes) onto 1 x 10<sup>4</sup> TZM-bl cells plated in 96-well plates, in the presence of 5 μg/ml of polybrene. Following spinoculation, the cells were washed three times with PBS and given fresh media. At 48 hours post infection, infectivity was measured by firefly luciferase assays following the manufacturers protocol (Promega). Luminescence was determined using the BMG Clariostar plate reader.</p>
</sec>
<sec id="sec017">
<title>Cell-cell fusion assay</title>
<p>Cf2Th cells stably expressing human or primate CD4 and human CCR5, and 293T cells, were plated at 3 x 10<sup>5</sup> and 1 x 10<sup>6</sup> cells/well of a 6-well dish, respectively. The next day, 1) Cf2Th cells were transfected with 2.5 μg of DNA (1.25 μg of ½ renilla luciferase [<xref ref-type="bibr" rid="pbio.3000304.ref079">79</xref>] and 1.25 μg of pCDNA3.1 filler DNA) using Lipofectamine 3000 (Invitrogen) and 2) 293T cells were transfected with 2.5 μg of DNA (1.25 μg of ½ renilla luciferase and 1.25 μg of the Env expression plasmid) using TransIT 293 (Mirus). Twenty-four hours post transfection, the cells were removed from the plate using an enzyme free 1X citric saline solution (10X solution, 1.35M KCl, 0.15M Sodium Citrate) diluted in PBS, counted, and resuspended to a final volume of 1x10<sup>5</sup> cells/ml. 100 μl of transfected cells in quadrupilicate (1 x 10<sup>4</sup> 293T and Cf2Th cells) were mixed 1:1 and incubated for 6 hours in 96-well flat bottom plates. Following incubation, fusion was assessed using a Renilla luciferase assay (Promega). Luminescence was determined using the BMG Clariostar plate reader.</p>
</sec>
<sec id="sec018">
<title>Data presentation and analysis</title>
<p>All data were plotted, and one-way ANOVA and Mann–Whitney U tests were performed where indicated, using Prism version 7.0a for mac (GraphPad). IC<sub>50</sub> values were determined by first normalizing the relative luminescence units as follows: 100% and 0% inhibition was defined by wells receiving the highest concentration of sCD4 and absence of sCD4, respectively. A nonlinear regression curve was fit to the normalized data, and IC<sub>50</sub> values were calculated using Prism (GraphPad) software.</p>
</sec>
<sec id="sec019">
<title>Ethics statement</title>
<p>The blood collections performed on the animals in this study were approved as protocol number 00000451-RN02 by the University of Texas, MD Anderson Cancer Center, Institutional Animal Care and Use Committee (MDACC-IACUC). The protocol approved by the MDACC-IACUC adhered to the recommendations provided in the <italic>Guide for the Care and Use of Laboratory Animals</italic> [<xref ref-type="bibr" rid="pbio.3000304.ref120">120</xref>] and also adhered to the blood collection volumes recommended by the Guidance Document of the Association of Primate Veterinarians (<ext-link ext-link-type="uri" xlink:href="https://www.primatevets.org/guidance-documents" xlink:type="simple">https://www.primatevets.org/guidance-documents</ext-link>) entitled <italic>Guidelines for Blood Sampling in Nonhuman Primates</italic> (also known as <italic>Blood Sampling Guidelines for Nonhuman Primates in Biomedical Research</italic>).</p>
</sec>
</sec>
<sec id="sec020">
<title>Supporting information</title>
<supplementary-material id="pbio.3000304.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Stable expression of human and primate CD4 receptors.</title>
<p>(A) Histograms of CD4 expression levels in Cf2Th cell lines engineered to stably express each primate CD4 receptor with human CCR5. (B) Gating strategy for enumerating the GFP+ (infected) cell population. Single stains of human CD4 (blue) and human CCR5 (red) as well as unstained cells (black) were used to denote receptor expression quadrants. A CD4 window was drawn such that it would capture equivalent CD4/CCR5 receptor expression across all stable cell lines shown in (A). GFP+ cells were enumerated within this window. (C) Surface expression of CD4 from human T cells (Hut-78 cells) and primate T cells that we isolated directly from primate blood. (D) Histograms of CD4 expression levels in Cf2Th cell lines with (red line) and without (black line) HIV-1 infection. Shaded histograms are from cells transduced with an empty vector control and denote the CD4-negative population. Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s011">S7 Data</xref>). CCR5, C-C motif chemokine receptor 5; GFP, green fluorescent protein.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Stable expression of primate CD4 and CCR5 receptors.</title>
<p>(A) Histograms of CD4 and CCR5 expression levels in Cf2Th cell lines made to stably express primate CD4/CCR5 receptor pairs from each primate species (top) or each primate CD4 paired with human CCR5 (bottom). (B) Cf2Th cell lines stably expressing primate CD4/CCR5 receptor pairs from each primate species (black bars) and each primate CD4 paired with human CCR5 (gray bars) were infected with HIV-1 GFP pseudotyped with a subtype A Envelope (BG505). Error bars represent the mean + SEM from two independent experiments, each with three technical replicates. Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s012">S8</xref> and <xref ref-type="supplementary-material" rid="pbio.3000304.s013">S9</xref> Datas). CCR5, C-C motif chemokine receptor 5; GFP, green fluorescent protein.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Production of human and primate sCD4 receptors.</title>
<p>(A, B, C) Size-exclusion profiles of (A) human, (B) chimpanzee, and (C) rhesus macaque soluble CD4 proteins (sCD4). The input sample is made from combined fractions eluted from the Ni-NTA column. Total protein was visualized using the TGX stain-free system (Bio-Rad). Fractions collected from the Superdex 75 column are each 1 ml. Fractions indicated with a red box eluted at a volume consistent with the molecular weight of sCD4 monomers and were combined for use in downstream experiments. Plots below the gels are A280 absorbance readings from the FPLC spectrophotometer. (D) Total protein stain of purified sCD4 molecules. Human, chimpanzee, and rhesus macaque CD4 are all differentially glycosylated, explaining the differences in migration [<xref ref-type="bibr" rid="pbio.3000304.ref048">48</xref>]. (E) HIV-1 pseudotyped with the indicated Envs (top of graphs), was preincubated with increasing concentrations of human sCD4 produced in this study (solid line; see panel A) or a commercially available sCD4 obtained from National Institutes of Health AIDS Reagent Program (#7356) (dashed line), and then used to infect TZM-bl cells. Error bars represent the SD from <italic>n</italic> = 4 technical replicates. Data associated with this figure can be found in the supplemental data file (<xref ref-type="supplementary-material" rid="pbio.3000304.s014">S10 Data</xref>). FPLC, fast protein liquid chromatography; TGX, Tris-Glycine eXtended</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s004" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Envelope clones used in this study.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s005" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s005" xlink:type="simple">
<label>S1 Data</label>
<caption>
<title>Raw values for the data in <xref ref-type="fig" rid="pbio.3000304.g001">Fig 1</xref>.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s006" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s006" xlink:type="simple">
<label>S2 Data</label>
<caption>
<title>Raw values for the data in <xref ref-type="fig" rid="pbio.3000304.g002">Fig 2</xref>.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s007" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s007" xlink:type="simple">
<label>S3 Data</label>
<caption>
<title>Raw values for the data in <xref ref-type="fig" rid="pbio.3000304.g003">Fig 3</xref>.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s008" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s008" xlink:type="simple">
<label>S4 Data</label>
<caption>
<title>Raw values for the data in <xref ref-type="fig" rid="pbio.3000304.g004">Fig 4</xref>.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s009" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s009" xlink:type="simple">
<label>S5 Data</label>
<caption>
<title>Raw values for the data in <xref ref-type="fig" rid="pbio.3000304.g005">Fig 5</xref>.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s010" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s010" xlink:type="simple">
<label>S6 Data</label>
<caption>
<title>Raw values for the data in <xref ref-type="fig" rid="pbio.3000304.g006">Fig 6</xref>.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s011" mimetype="application/zip" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s011" xlink:type="simple">
<label>S7 Data</label>
<caption>
<title>Flow cytometry files corresponding to <xref ref-type="supplementary-material" rid="pbio.3000304.s001">S1 Fig</xref>.</title>
<p>(ZIP)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s012" mimetype="application/zip" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s012" xlink:type="simple">
<label>S8 Data</label>
<caption>
<title>Flow cytometry files corresponding to <xref ref-type="supplementary-material" rid="pbio.3000304.s002">S2 Fig</xref>.</title>
<p>(ZIP)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s013" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s013" xlink:type="simple">
<label>S9 Data</label>
<caption>
<title>Raw values for the data in <xref ref-type="supplementary-material" rid="pbio.3000304.s002">S2 Fig</xref>.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000304.s014" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000304.s014" xlink:type="simple">
<label>S10 Data</label>
<caption>
<title>Raw values for the data in <xref ref-type="supplementary-material" rid="pbio.3000304.s003">S3 Fig</xref>.</title>
<p>(PZFX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Julie Overbaugh, Soraya Shehata and Joe Timpona for comments on the manuscript.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>CCR5</term>
<def><p>C-C motif chemokine receptor 5</p></def>
</def-item>
<def-item><term>CXCR4</term>
<def><p>C-X-C motif chemokine receptor 4</p></def>
</def-item>
<def-item><term>Env</term>
<def><p>Envelope</p></def>
</def-item>
<def-item><term>GFP</term>
<def><p>green fluorescent protein</p></def>
</def-item>
<def-item><term>PBMC</term>
<def><p>peripheral blood mononuclear cells</p></def>
</def-item>
<def-item><term>sCD4</term>
<def><p>soluble CD4</p></def>
</def-item>
<def-item><term>SIV</term>
<def><p>simian immunodeficiency virus</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pbio.3000304.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sagar</surname> <given-names>M</given-names></name>. <article-title>HIV-1 transmission biology: selection and characteristics of infecting viruses</article-title>. <source>J Infect Dis</source>. <year>2010</year>; <volume>202</volume> <issue>Suppl 2</issue>: <fpage>S289</fpage>–<lpage>96</lpage>.</mixed-citation></ref>
<ref id="pbio.3000304.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kearney</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Maldarelli</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Shao</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Margolick</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Daar</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Mellors</surname> <given-names>JW</given-names></name>, <etal>et al</etal>. <article-title>Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals</article-title>. <source>J Virol</source>. <year>2009</year>; <volume>83</volume>: <fpage>2715</fpage>–<lpage>2727</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01960-08" xlink:type="simple">10.1128/JVI.01960-08</ext-link></comment> <object-id pub-id-type="pmid">19116249</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Keele</surname> <given-names>BF</given-names></name>, <name name-style="western"><surname>Giorgi</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Salazar-Gonzalez</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Decker</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Pham</surname> <given-names>KT</given-names></name>, <name name-style="western"><surname>Salazar</surname> <given-names>MG</given-names></name>, <etal>et al</etal>. <article-title>Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2008</year>; <volume>105</volume>: <fpage>7552</fpage>–<lpage>7557</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0802203105" xlink:type="simple">10.1073/pnas.0802203105</ext-link></comment> <object-id pub-id-type="pmid">18490657</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abrahams</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Giorgi</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Seoighe</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mlisana</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ping</surname> <given-names>LH</given-names></name>, <etal>et al</etal>. <article-title>Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants</article-title>. <source>J Virol</source>. <year>2009</year>; <volume>83</volume>: <fpage>3556</fpage>–<lpage>3567</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02132-08" xlink:type="simple">10.1128/JVI.02132-08</ext-link></comment> <object-id pub-id-type="pmid">19193811</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Derdeyn</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Decker</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Bibollet-Ruche</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Mokili</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Muldoon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Denham</surname> <given-names>SA</given-names></name>, <etal>et al</etal>. <article-title>Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission</article-title>. <source>Science</source>. <year>2004</year>; <volume>303</volume>: <fpage>2019</fpage>–<lpage>2022</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1093137" xlink:type="simple">10.1126/science.1093137</ext-link></comment> <object-id pub-id-type="pmid">15044802</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tully</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Ogilvie</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Batorsky</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Bean</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Power</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Ghebremichael</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus</article-title>. <source>PLoS Pathog</source>. <year>2016</year>; <volume>12</volume>: <fpage>e1005619</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1005619" xlink:type="simple">10.1371/journal.ppat.1005619</ext-link></comment> <object-id pub-id-type="pmid">27163788</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bar</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Chamberland</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tremblay</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Routy</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Grayson</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Wide variation in the multiplicity of HIV-1 infection among injection drug users</article-title>. <source>J Virol</source>. <year>2010</year>; <volume>84</volume>: <fpage>6241</fpage>–<lpage>6247</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00077-10" xlink:type="simple">10.1128/JVI.00077-10</ext-link></comment> <object-id pub-id-type="pmid">20375173</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Masharsky</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Dukhovlinova</surname> <given-names>EN</given-names></name>, <name name-style="western"><surname>Verevochkin</surname> <given-names>SV</given-names></name>, <name name-style="western"><surname>Toussova</surname> <given-names>OV</given-names></name>, <name name-style="western"><surname>Skochilov</surname> <given-names>RV</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia</article-title>. <source>J Infect Dis</source>. <year>2010</year>; <volume>201</volume>: <fpage>1697</fpage>–<lpage>1702</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/652702" xlink:type="simple">10.1086/652702</ext-link></comment> <object-id pub-id-type="pmid">20423223</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Parast</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Richardson</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Nduati</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>John-Stewart</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Mbori-Ngacha</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant</article-title>. <source>J Virol</source>. <year>2006</year>; <volume>80</volume>: <fpage>835</fpage>–<lpage>844</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.80.2.835-844.2006" xlink:type="simple">10.1128/JVI.80.2.835-844.2006</ext-link></comment> <object-id pub-id-type="pmid">16378985</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parker</surname> <given-names>ZF</given-names></name>, <name name-style="western"><surname>Iyer</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Wilen</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Parrish</surname> <given-names>NF</given-names></name>, <name name-style="western"><surname>Chikere</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>FH</given-names></name>, <etal>et al</etal>. <article-title>Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5</article-title>. <source>J Virol</source>. <year>2013</year>; <volume>87</volume>: <fpage>2401</fpage>–<lpage>2411</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02964-12" xlink:type="simple">10.1128/JVI.02964-12</ext-link></comment> <object-id pub-id-type="pmid">23269796</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Go</surname> <given-names>EP</given-names></name>, <name name-style="western"><surname>Hewawasam</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Liao</surname> <given-names>H-X</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ping</surname> <given-names>L-H</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry</article-title>. <source>J Virol</source>. <year>2011</year>; <volume>85</volume>: <fpage>8270</fpage>–<lpage>8284</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.05053-11" xlink:type="simple">10.1128/JVI.05053-11</ext-link></comment> <object-id pub-id-type="pmid">21653661</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Curlin</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Diem</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ghosh</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses</article-title>. <source>Virology</source>. <year>2008</year>; <volume>374</volume>: <fpage>229</fpage>–<lpage>233</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virol.2008.01.029" xlink:type="simple">10.1016/j.virol.2008.01.029</ext-link></comment> <object-id pub-id-type="pmid">18314154</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liao</surname> <given-names>HX</given-names></name>, <name name-style="western"><surname>Tsao</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Alam</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Muldoon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Vandergrift</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>BJ</given-names></name>, <etal>et al</etal>. <article-title>Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1</article-title>. <source>J Virol</source>. <year>2013</year>; <volume>87</volume>: <fpage>4185</fpage>–<lpage>4201</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02297-12" xlink:type="simple">10.1128/JVI.02297-12</ext-link></comment> <object-id pub-id-type="pmid">23365441</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Foster</surname> <given-names>TL</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Iyer</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Coss</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Doores</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction</article-title>. <source>Cell Host Microbe</source>. <year>2016</year>; <volume>20</volume>: <fpage>429</fpage>–<lpage>442</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chom.2016.08.006" xlink:type="simple">10.1016/j.chom.2016.08.006</ext-link></comment> <object-id pub-id-type="pmid">27640936</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fenton-May</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Dibben</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Emmerich</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ding</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Pfafferott</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Aasa-Chapman</surname> <given-names>MM</given-names></name>, <etal>et al</etal>. <article-title>Relative resistance of HIV-1 founder viruses to control by interferon-alpha</article-title>. <source>Retrovirology</source>. <year>2013</year>; <volume>10</volume>: <fpage>146</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1742-4690-10-146" xlink:type="simple">10.1186/1742-4690-10-146</ext-link></comment> <object-id pub-id-type="pmid">24299076</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Warren</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>. <article-title>How host genetics dictates successful viral zoonosis</article-title>. <source>PLoS Biol</source>. <year>2019</year>; <volume>17</volume>: <fpage>e3000217</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.3000217" xlink:type="simple">10.1371/journal.pbio.3000217</ext-link></comment> <object-id pub-id-type="pmid">31002666</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sharp</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Hahn</surname> <given-names>BH</given-names></name>. <article-title>Origins of HIV and the AIDS pandemic</article-title>. <source>Cold Spring Harb Perspect Med</source>. <year>2011</year>; <volume>1</volume>: <fpage>a006841</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a006841" xlink:type="simple">10.1101/cshperspect.a006841</ext-link></comment> <object-id pub-id-type="pmid">22229120</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hatziioannou</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Evans</surname> <given-names>DT</given-names></name>. <article-title>Animal models for HIV/AIDS research</article-title>. <source>Nat Rev Micro</source>. <year>2012</year>; <volume>10</volume>: <fpage>852</fpage>–<lpage>867</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrmicro2911" xlink:type="simple">10.1038/nrmicro2911</ext-link></comment> <object-id pub-id-type="pmid">23154262</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bell</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Bedford</surname> <given-names>T</given-names></name>. <article-title>Modern-day SIV viral diversity generated by extensive recombination and cross-species transmission</article-title>. <source>PLoS Pathog</source>. <year>2017</year>;<volume>13</volume>: <fpage>e1006466</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1006466" xlink:type="simple">10.1371/journal.ppat.1006466</ext-link></comment> <object-id pub-id-type="pmid">28672035</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>ZD</given-names></name>, <name name-style="western"><surname>Weinstock</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gerstein</surname> <given-names>M</given-names></name>. <article-title>Rapid evolution by positive Darwinian selection in T-cell antigen CD4 in primates</article-title>. <source>J Mol Evol</source>. <year>2008</year>; <volume>66</volume>: <fpage>446</fpage>–<lpage>456</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00239-008-9097-1" xlink:type="simple">10.1007/s00239-008-9097-1</ext-link></comment> <object-id pub-id-type="pmid">18414925</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyerson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Rowley</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Swan</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Le</surname> <given-names>DT</given-names></name>, <name name-style="western"><surname>Wilkerson</surname> <given-names>GK</given-names></name>, <name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>. <article-title>Positive selection of primate genes that promote HIV-1 replication</article-title>. <source>Virology</source>. <year>2014</year>; <volume>454–455</volume>: <fpage>291</fpage>–<lpage>298</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virol.2014.02.029" xlink:type="simple">10.1016/j.virol.2014.02.029</ext-link></comment> <object-id pub-id-type="pmid">24725956</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Demogines</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Abraham</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Choe</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Farzan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>. <article-title>Dual host-virus arms races shape an essential housekeeping protein</article-title>. <source>PLoS Biol</source>. <year>2013</year>; <volume>11</volume>: <fpage>e1001571</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1001571" xlink:type="simple">10.1371/journal.pbio.1001571</ext-link></comment> <object-id pub-id-type="pmid">23723737</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Demogines</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Farzan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>. <article-title>Evidence for ACE2-utilizing coronaviruses (CoVs) related to severe acute respiratory syndrome CoV in bats</article-title>. <source>J Virol</source>. <year>2012</year>; <volume>86</volume>: <fpage>6350</fpage>–<lpage>6353</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00311-12" xlink:type="simple">10.1128/JVI.00311-12</ext-link></comment> <object-id pub-id-type="pmid">22438550</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaelber</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Demogines</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Harbison</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Allison</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Goodman</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Ortega</surname> <given-names>AN</given-names></name>, <etal>et al</etal>. <article-title>Evolutionary reconstructions of the transferrin receptor of Caniforms supports canine parvovirus being a re-emerged and not a novel pathogen in dogs</article-title>. <source>PLoS Pathog</source>. <year>2012</year>; <volume>8</volume>: <fpage>e1002666</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1002666" xlink:type="simple">10.1371/journal.ppat.1002666</ext-link></comment> <object-id pub-id-type="pmid">22570610</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kerr</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Jackson</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Lungu</surname> <given-names>OI</given-names></name>, <name name-style="western"><surname>Meyer</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Demogines</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ellington</surname> <given-names>AD</given-names></name>, <etal>et al</etal>. <article-title>Computational and Functional Analysis of the Virus-Receptor Interface Reveals Host Range Trade-Offs in New World Arenaviruses</article-title>. <source>J Virol</source>. <year>2015</year>; <volume>89</volume>: <fpage>11643</fpage>–<lpage>11653</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01408-15" xlink:type="simple">10.1128/JVI.01408-15</ext-link></comment> <object-id pub-id-type="pmid">26355089</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Buckler-White</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wollenberg</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kozak</surname> <given-names>CA</given-names></name>. <article-title>The avian XPR1 gammaretrovirus receptor is under positive selection and is disabled in bird species in contact with virus-infected wild mice</article-title>. <source>J Virol</source>. <year>2013</year>; <volume>87</volume>: <fpage>10094</fpage>–<lpage>10104</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01327-13" xlink:type="simple">10.1128/JVI.01327-13</ext-link></comment> <object-id pub-id-type="pmid">23843647</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyerson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>. <article-title>Two-stepping through time: mammals and viruses</article-title>. <source>Trends Microbiol</source>. <year>2011</year>; <volume>19</volume>: <fpage>286</fpage>–<lpage>294</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tim.2011.03.006" xlink:type="simple">10.1016/j.tim.2011.03.006</ext-link></comment> <object-id pub-id-type="pmid">21531564</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Acharya</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dolan</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Guzzo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer</article-title>. <source>Nat Struct Mol Biol</source>. <year>2017</year>; <volume>24</volume>: <fpage>370</fpage>–<lpage>378</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nsmb.3382" xlink:type="simple">10.1038/nsmb.3382</ext-link></comment> <object-id pub-id-type="pmid">28218750</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Joseph</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Swanstrom</surname> <given-names>R</given-names></name>. <article-title>The evolution of HIV-1 entry phenotypes as a guide to changing target cells</article-title>. <source>J Leukoc Biol</source>. <year>2018</year>; <volume>103</volume>: <fpage>421</fpage>–<lpage>431</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/JLB.2RI0517-200R" xlink:type="simple">10.1002/JLB.2RI0517-200R</ext-link></comment> <object-id pub-id-type="pmid">29389021</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Humes</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Overbaugh</surname> <given-names>J</given-names></name>. <article-title>Adaptation of Subtype A Human Immunodeficiency Virus Type 1 Envelope to Pig-Tailed Macaque Cells</article-title>. <source>J Virol</source>. <year>2011</year>; <volume>85</volume>: <fpage>4409</fpage>–<lpage>4420</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02244-10" xlink:type="simple">10.1128/JVI.02244-10</ext-link></comment> <object-id pub-id-type="pmid">21325401</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Humes</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Emery</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Laws</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Overbaugh</surname> <given-names>J</given-names></name>. <article-title>A Species-Specific Amino Acid Difference in the Macaque CD4 Receptor Restricts Replication by Global Circulating HIV-1 Variants Representing Viruses from Recent Infection</article-title>. <source>J Virol</source>. <year>2012</year>; <volume>86</volume>: <fpage>12472</fpage>–<lpage>12483</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02176-12" xlink:type="simple">10.1128/JVI.02176-12</ext-link></comment> <object-id pub-id-type="pmid">22973036</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Del Prete</surname> <given-names>GQ</given-names></name>, <name name-style="western"><surname>Ailers</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Moldt</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Keele</surname> <given-names>BF</given-names></name>, <name name-style="western"><surname>Estes</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Rodriguez</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Selection of Unadapted, Pathogenic SHIVs Encoding Newly Transmitted HIV-1 Envelope Proteins</article-title>. <source>Cell Host Microbe</source>. <year>2014</year>; <volume>16</volume>: <fpage>412</fpage>–<lpage>418</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chom.2014.08.003" xlink:type="simple">10.1016/j.chom.2014.08.003</ext-link></comment> <object-id pub-id-type="pmid">25211081</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyerson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Sharma</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wilkerson</surname> <given-names>GK</given-names></name>, <name name-style="western"><surname>Overbaugh</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>. <article-title>Identification of Owl Monkey CD4 Receptors Broadly Compatible with Early-Stage HIV-1 Isolates</article-title>. <source>J Virol</source>. <year>2015</year>; <volume>89</volume>: <fpage>8611</fpage>–<lpage>8622</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00890-15" xlink:type="simple">10.1128/JVI.00890-15</ext-link></comment> <object-id pub-id-type="pmid">26063421</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohen</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Gay</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Busch</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Hecht</surname> <given-names>FM</given-names></name>. <article-title>The detection of acute HIV infection</article-title>. <source>J Infect Dis</source>. <year>2010</year>; <volume>202</volume> <issue>Suppl 2</issue>: <fpage>S270</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/655651" xlink:type="simple">10.1086/655651</ext-link></comment> <object-id pub-id-type="pmid">20846033</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fiebig</surname> <given-names>EW</given-names></name>, <name name-style="western"><surname>Wright</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Rawal</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Garrett</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Schumacher</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Peddada</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection</article-title>. <source>AIDS</source>. <year>2003</year>; <volume>17</volume>: <fpage>1871</fpage>–<lpage>1879</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/01.aids.0000076308.76477.b8" xlink:type="simple">10.1097/01.aids.0000076308.76477.b8</ext-link></comment> <object-id pub-id-type="pmid">12960819</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Salazar-Gonzalez</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Derdeyn</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Morris</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Williamson</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Robinson</surname> <given-names>JE</given-names></name>, <etal>et al</etal>. <article-title>Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa</article-title>. <source>J Virol</source>. <year>2006</year>;<volume>80</volume>: <fpage>11776</fpage>–<lpage>11790</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01730-06" xlink:type="simple">10.1128/JVI.01730-06</ext-link></comment> <object-id pub-id-type="pmid">16971434</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Etemad</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Fellows</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kwambana</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Kamat</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection</article-title>. <source>J Virol</source>. <year>2009</year>; <volume>83</volume>: <fpage>9694</fpage>–<lpage>9708</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00925-09" xlink:type="simple">10.1128/JVI.00925-09</ext-link></comment> <object-id pub-id-type="pmid">19625411</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Cohen</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Galimidi</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Gristick</surname> <given-names>HB</given-names></name>, <name name-style="western"><surname>Jensen</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Bjorkman</surname> <given-names>PJ</given-names></name>. <article-title>Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2016</year>; <volume>113</volume>: <fpage>E7151</fpage>–<lpage>E7158</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1615939113" xlink:type="simple">10.1073/pnas.1615939113</ext-link></comment> <object-id pub-id-type="pmid">27799557</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sanders</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Derking</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Cupo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Julien</surname> <given-names>J-P</given-names></name>, <name name-style="western"><surname>Yasmeen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>de Val</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies</article-title>. <source>PLoS Pathog</source>. <year>2013</year>; <volume>9</volume>: <fpage>e1003618</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1003618" xlink:type="simple">10.1371/journal.ppat.1003618</ext-link></comment> <object-id pub-id-type="pmid">24068931</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sanders</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Moore</surname> <given-names>JP</given-names></name>. <article-title>Native-like Env trimers as a platform for HIV-1 vaccine design</article-title>. <source>Immunol Rev</source>. <year>2017</year>; <volume>275</volume>: <fpage>161</fpage>–<lpage>182</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/imr.12481" xlink:type="simple">10.1111/imr.12481</ext-link></comment> <object-id pub-id-type="pmid">28133806</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Castillo-Menendez</surname> <given-names>LR</given-names></name>, <name name-style="western"><surname>Gorman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Alsahafi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ermel</surname> <given-names>U</given-names></name>, <etal>et al</etal>. <article-title>Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET</article-title>. <source>Nature</source>. <year>2019</year>; <volume>568</volume>: <fpage>415</fpage>–<lpage>419</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41586-019-1101-y" xlink:type="simple">10.1038/s41586-019-1101-y</ext-link></comment> <object-id pub-id-type="pmid">30971821</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poss</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Overbaugh</surname> <given-names>J</given-names></name>. <article-title>Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties</article-title>. <source>J Virol</source>. <year>1999</year>; <volume>73</volume>: <fpage>5255</fpage>–<lpage>5264</lpage>. <object-id pub-id-type="pmid">10364271</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ryu</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Kwong</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Truneh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Porter</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Arthos</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rosenberg</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Crystal structure of an HIV-binding recombinant fragment of human CD4</article-title>. <source>Nature</source>. <year>1990</year>; <volume>348</volume>: <fpage>419</fpage>–<lpage>426</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/348419a0" xlink:type="simple">10.1038/348419a0</ext-link></comment> <object-id pub-id-type="pmid">2247146</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Yan</surname> <given-names>YW</given-names></name>, <name name-style="western"><surname>Garrett</surname> <given-names>TP</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Rodgers</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Garlick</surname> <given-names>RL</given-names></name>, <etal>et al</etal>. <article-title>Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains</article-title>. <source>Nature</source>. <year>1990</year>; <volume>348</volume>: <fpage>411</fpage>–<lpage>418</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/348411a0" xlink:type="simple">10.1038/348411a0</ext-link></comment> <object-id pub-id-type="pmid">1701030</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kwong</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Wyatt</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Robinson</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sweet</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Sodroski</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hendrickson</surname> <given-names>WA</given-names></name>. <article-title>Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody</article-title>. <source>Nature</source>. <year>1998</year>; <volume>393</volume>: <fpage>648</fpage>–<lpage>659</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/31405" xlink:type="simple">10.1038/31405</ext-link></comment> <object-id pub-id-type="pmid">9641677</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arthos</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Deen</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Chaikin</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Fornwald</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Sathe</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sattentau</surname> <given-names>QJ</given-names></name>, <etal>et al</etal>. <article-title>Identification of the residues in human CD4 critical for the binding of HIV</article-title>. <source>Cell</source>. <year>1989</year>; <volume>57</volume>: <fpage>469</fpage>–<lpage>481</lpage>. <object-id pub-id-type="pmid">2541915</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landau</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Warton</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Littman</surname> <given-names>DR</given-names></name>. <article-title>The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4</article-title>. <source>Nature</source>. <year>1988</year>; <volume>334</volume>: <fpage>159</fpage>–<lpage>162</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/334159a0" xlink:type="simple">10.1038/334159a0</ext-link></comment> <object-id pub-id-type="pmid">3260352</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Warren</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Meyerson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Stabell</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Fattor</surname> <given-names>WT</given-names></name>, <name name-style="western"><surname>Wilkerson</surname> <given-names>GK</given-names></name>, <name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>. <article-title>A glycan shield on chimpanzee CD4 protects against infection by primate lentiviruses (HIV/SIV)</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2019</year>; <volume>116</volume>: <fpage>3229</fpage>–<lpage>3238</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1821197116" xlink:type="simple">10.1073/pnas.1821197116</ext-link></comment></mixed-citation></ref>
<ref id="pbio.3000304.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>deCamp</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hraber</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Bailer</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Seaman</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Ochsenbauer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kappes</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies</article-title>. <source>J Virol</source>. <year>2014</year>;<volume>88</volume>: <fpage>2489</fpage>–<lpage>2507</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02853-13" xlink:type="simple">10.1128/JVI.02853-13</ext-link></comment> <object-id pub-id-type="pmid">24352443</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parrish</surname> <given-names>NF</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Giorgi</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Barbian</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Parrish</surname> <given-names>EH</given-names></name>, <etal>et al</etal>. <article-title>Phenotypic properties of transmitted founder HIV-1</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2013</year>;<volume>110</volume>: <fpage>6626</fpage>–<lpage>6633</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1304288110" xlink:type="simple">10.1073/pnas.1304288110</ext-link></comment> <object-id pub-id-type="pmid">23542380</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Freel</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Picking</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Ferrari</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ding</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ochsenbauer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kappes</surname> <given-names>JC</given-names></name>, <etal>et al</etal>. <article-title>Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication</article-title>. <source>J Virol</source>. <year>2012</year>; <volume>86</volume>: <fpage>6835</fpage>–<lpage>6846</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00437-12" xlink:type="simple">10.1128/JVI.00437-12</ext-link></comment> <object-id pub-id-type="pmid">22514337</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blish</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Jalalian-Lechak</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Rainwater</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>M-A</given-names></name>, <name name-style="western"><surname>Dogan</surname> <given-names>OC</given-names></name>, <name name-style="western"><surname>Overbaugh</surname> <given-names>J</given-names></name>. <article-title>Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1</article-title>. <source>J Virol</source>. <year>2009</year>; <volume>83</volume>: <fpage>7783</fpage>–<lpage>7788</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00673-09" xlink:type="simple">10.1128/JVI.00673-09</ext-link></comment> <object-id pub-id-type="pmid">19474105</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Mascola</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Stamatatos</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Polonis</surname> <given-names>VR</given-names></name>, <name name-style="western"><surname>Koutsoukos</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies</article-title>. <source>J Virol</source>. <year>2005</year>; <volume>79</volume>: <fpage>10108</fpage>–<lpage>10125</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.79.16.10108-10125.2005" xlink:type="simple">10.1128/JVI.79.16.10108-10125.2005</ext-link></comment> <object-id pub-id-type="pmid">16051804</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Swanstrom</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Graham</surname> <given-names>WD</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>S</given-names></name>. <article-title>Sequencing the Biology of Entry: The Retroviral env Gene</article-title>. <source>Curr Top Microbiol Immunol</source>. <year>2017</year>; <volume>407</volume>: <fpage>65</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/82_2017_35" xlink:type="simple">10.1007/82_2017_35</ext-link></comment> <object-id pub-id-type="pmid">28688086</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ping</surname> <given-names>L-H</given-names></name>, <name name-style="western"><surname>Joseph</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Abrahams</surname> <given-names>M-R</given-names></name>, <name name-style="western"><surname>Salazar-Gonzalez</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Kincer</surname> <given-names>LP</given-names></name>, <etal>et al</etal>. <article-title>Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design</article-title>. <source>J Virol</source>. <year>2013</year>; <volume>87</volume>: <fpage>7218</fpage>–<lpage>7233</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.03577-12" xlink:type="simple">10.1128/JVI.03577-12</ext-link></comment> <object-id pub-id-type="pmid">23616655</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parrish</surname> <given-names>NF</given-names></name>, <name name-style="western"><surname>Wilen</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Banks</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Iyer</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Pfaff</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Salazar-Gonzalez</surname> <given-names>JF</given-names></name>, <etal>et al</etal>. <article-title>Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7</article-title>. <source>PLoS Pathog</source>. <year>2012</year>; <volume>8</volume>: <fpage>e1002686</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1002686" xlink:type="simple">10.1371/journal.ppat.1002686</ext-link></comment> <object-id pub-id-type="pmid">22693444</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sheppard</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Celum</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Michael</surname> <given-names>NL</given-names></name>, <name name-style="western"><surname>O'Brien</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Dean</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Carrington</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion</article-title>. <source>J AIDS</source>. <year>2002</year>; <volume>29</volume>: <fpage>307</fpage>–<lpage>313</lpage>.</mixed-citation></ref>
<ref id="pbio.3000304.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oh</surname> <given-names>D-Y</given-names></name>, <name name-style="western"><surname>Jessen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kücherer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Neumann</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Poggensee</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual</article-title>. <source>PLoS ONE</source>. <year>2008</year>; <volume>3</volume>: <fpage>e2747</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0002747" xlink:type="simple">10.1371/journal.pone.0002747</ext-link></comment> <object-id pub-id-type="pmid">18648518</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Eshleman</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Toma</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stawiski</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Whitcomb</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Jackson</surname> <given-names>JB</given-names></name>, <etal>et al</etal>. <article-title>Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs</article-title>. <source>AIDS</source>. <year>2009</year>; <volume>23</volume>: <fpage>1903</fpage>–<lpage>1908</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/QAD.0b013e32832f1802" xlink:type="simple">10.1097/QAD.0b013e32832f1802</ext-link></comment> <object-id pub-id-type="pmid">19593079</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Toma</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stawiski</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Fransen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wrin</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Parkin</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>2009</year>; <volume>25</volume>: <fpage>795</fpage>–<lpage>802</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/aid.2008.0252" xlink:type="simple">10.1089/aid.2008.0252</ext-link></comment> <object-id pub-id-type="pmid">19678765</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Mendoza</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Rodriguez</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>García</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Eiros</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Ruiz</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Caballero</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance</article-title>. <source>J Antimicrob Chemother</source>. <year>2007</year>; <volume>59</volume>: <fpage>698</fpage>–<lpage>704</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jac/dkm012" xlink:type="simple">10.1093/jac/dkm012</ext-link></comment> <object-id pub-id-type="pmid">17327295</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Satomi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shimizu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shinya</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Watari</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Owaki</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hidaka</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN</article-title>. <source>J Infect Dis</source>. <year>2005</year>; <volume>191</volume>: <fpage>174</fpage>–<lpage>181</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/426829" xlink:type="simple">10.1086/426829</ext-link></comment> <object-id pub-id-type="pmid">15609226</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peters</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Sullivan</surname> <given-names>WM</given-names></name>, <name name-style="western"><surname>Dueñas-Decamp</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Bhattacharya</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ankghuambom</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis</article-title>. <source>J Virol</source>. <year>2006</year>; <volume>80</volume>: <fpage>6324</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02328-05" xlink:type="simple">10.1128/JVI.02328-05</ext-link></comment> <object-id pub-id-type="pmid">16775320</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheng-Mayer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Landau</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Stamatatos</surname> <given-names>L</given-names></name>. <article-title>Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor</article-title>. <source>J Virol</source>. <year>1997</year>; <volume>71</volume>: <fpage>1657</fpage>–<lpage>1661</lpage>. <object-id pub-id-type="pmid">8995695</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stamatatos</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lim</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cheng-Mayer</surname> <given-names>C</given-names></name>. <article-title>Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>2000</year>; <volume>16</volume>: <fpage>981</fpage>–<lpage>994</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/08892220050058407" xlink:type="simple">10.1089/08892220050058407</ext-link></comment> <object-id pub-id-type="pmid">10890360</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stamatatos</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wiskerchen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cheng-Mayer</surname> <given-names>C</given-names></name>. <article-title>Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>1998</year>; <volume>14</volume>: <fpage>1129</fpage>–<lpage>1139</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/aid.1998.14.1129" xlink:type="simple">10.1089/aid.1998.14.1129</ext-link></comment> <object-id pub-id-type="pmid">9737584</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheng-Mayer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Levy</surname> <given-names>JA</given-names></name>. <article-title>Distinct biological and serological properties of human immunodeficiency viruses from the brain</article-title>. <source>Ann Neurol</source>. <year>1988</year>; <volume>23</volume>: <fpage>S58</fpage>–<lpage>S61</lpage>. <object-id pub-id-type="pmid">3258140</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hui</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Burgess</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Price</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Sharp</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Hahn</surname> <given-names>BH</given-names></name>, <etal>et al</etal>. <article-title>Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation</article-title>. <source>J Virol</source>. <year>1992</year>; <volume>66</volume>: <fpage>6587</fpage>–<lpage>6600</lpage>. <object-id pub-id-type="pmid">1404605</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Svehla</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mathy</surname> <given-names>NL</given-names></name>, <name name-style="western"><surname>Voss</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Mascola</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Wyatt</surname> <given-names>R</given-names></name>. <article-title>Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants</article-title>. <source>J Virol</source>. <year>2006</year>; <volume>80</volume>: <fpage>1414</fpage>–<lpage>1426</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.80.3.1414-1426.2006" xlink:type="simple">10.1128/JVI.80.3.1414-1426.2006</ext-link></comment> <object-id pub-id-type="pmid">16415019</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gartner</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Markovits</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Markovitz</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Kaplan</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Gallo</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Popovic</surname> <given-names>M</given-names></name>. <article-title>The role of mononuclear phagocytes in HTLV-III/LAV infection</article-title>. <source>Science</source>. <year>1986</year>; <volume>233</volume>: <fpage>215</fpage>–<lpage>219</lpage>. <object-id pub-id-type="pmid">3014648</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carter</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Onafuwa-Nuga</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>McNamara</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Riddell</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bixby</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Savona</surname> <given-names>MR</given-names></name>, <etal>et al</etal>. <article-title>HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs</article-title>. <source>Nat Med</source>. <year>2010</year>; <volume>16</volume>: <fpage>446</fpage>–<lpage>451</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.2109" xlink:type="simple">10.1038/nm.2109</ext-link></comment> <object-id pub-id-type="pmid">20208541</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Collman</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Balliet</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Gregory</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Friedman</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kolson</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Nathanson</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1</article-title>. <source>J Virol</source>. <year>1992</year>; <volume>66</volume>: <fpage>7517</fpage>–<lpage>7521</lpage>. <object-id pub-id-type="pmid">1433527</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salimi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Roche</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Gray</surname> <given-names>LR</given-names></name>, <name name-style="western"><surname>Chikere</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sterjovski</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5</article-title>. <source>J Leukoc Biol</source>. <year>2013</year>; <volume>93</volume>: <fpage>113</fpage>–<lpage>126</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1189/jlb.0612308" xlink:type="simple">10.1189/jlb.0612308</ext-link></comment> <object-id pub-id-type="pmid">23077246</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Joseph</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Arrildt</surname> <given-names>KT</given-names></name>, <name name-style="western"><surname>Swanstrom</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Schnell</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hoxie</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities</article-title>. <source>J Virol</source>. <year>2014</year>; <volume>88</volume>: <fpage>1858</fpage>–<lpage>1869</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02477-13" xlink:type="simple">10.1128/JVI.02477-13</ext-link></comment> <object-id pub-id-type="pmid">24307580</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomas</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>Dunfee</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Stanton</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bogdan</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kunstman</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion</article-title>. <source>Virology</source>. <year>2007</year>; <volume>360</volume>: <fpage>105</fpage>–<lpage>119</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virol.2006.09.036" xlink:type="simple">10.1016/j.virol.2006.09.036</ext-link></comment> <object-id pub-id-type="pmid">17084877</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Byrn</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Marsters</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Gregory</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Groopman</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Capon</surname> <given-names>DJ</given-names></name>. <article-title>Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen</article-title>. <source>Science</source>. <year>1987</year>; <volume>238</volume>: <fpage>1704</fpage>–<lpage>1707</lpage>. <object-id pub-id-type="pmid">3500514</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kong</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ding</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>F-H</given-names></name>, <name name-style="western"><surname>Parker</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2016</year>; <volume>113</volume>: <fpage>E3413</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1606636113" xlink:type="simple">10.1073/pnas.1606636113</ext-link></comment> <object-id pub-id-type="pmid">27247400</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Del Prete</surname> <given-names>GQ</given-names></name>, <name name-style="western"><surname>Keele</surname> <given-names>BF</given-names></name>, <name name-style="western"><surname>Fode</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Thummar</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Swanstrom</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Rodriguez</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>A single gp120 residue can affect HIV-1 tropism in macaques</article-title>. <source>PLoS Pathog</source>. <year>2017</year>; <volume>13</volume>: <fpage>e1006572</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1006572" xlink:type="simple">10.1371/journal.ppat.1006572</ext-link></comment> <object-id pub-id-type="pmid">28945790</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kondo</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Miyauchi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Meng</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Iwamoto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Matsuda</surname> <given-names>Z</given-names></name>. <article-title>Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain</article-title>. <source>J Biol Chem</source>. <year>2010</year>; <volume>285</volume>: <fpage>14681</fpage>–<lpage>14688</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M109.067090" xlink:type="simple">10.1074/jbc.M109.067090</ext-link></comment> <object-id pub-id-type="pmid">20197275</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bibollet-Ruche</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Russell</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Stewart-Jones</surname> <given-names>GBE</given-names></name>, <name name-style="western"><surname>Sherrill-Mix</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>CD4 receptor diversity in chimpanzees protects against SIV infection</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2019</year>; <volume>11</volume>: <fpage>201821197</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1821197116" xlink:type="simple">10.1073/pnas.1821197116</ext-link></comment> <object-id pub-id-type="pmid">30718403</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stephens</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Donnelly</surname> <given-names>P</given-names></name>. <article-title>A new statistical method for haplotype reconstruction from population data</article-title>. <source>Am J Hum Genet</source>. <year>2001</year>; <volume>68</volume>: <fpage>978</fpage>–<lpage>989</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/319501" xlink:type="simple">10.1086/319501</ext-link></comment> <object-id pub-id-type="pmid">11254454</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref082"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stephens</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Donnelly</surname> <given-names>P</given-names></name>. <article-title>A comparison of bayesian methods for haplotype reconstruction from population genotype data</article-title>. <source>Am J Hum Genet</source>. <year>2003</year>; <volume>73</volume>: <fpage>1162</fpage>–<lpage>1169</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/379378" xlink:type="simple">10.1086/379378</ext-link></comment> <object-id pub-id-type="pmid">14574645</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref083"><label>83</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Librado</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Rozas</surname> <given-names>J</given-names></name>. <article-title>DnaSP v5: a software for comprehensive analysis of DNA polymorphism data</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>: <fpage>1451</fpage>–<lpage>1452</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btp187" xlink:type="simple">10.1093/bioinformatics/btp187</ext-link></comment> <object-id pub-id-type="pmid">19346325</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref084"><label>84</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Malim</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Bieniasz</surname> <given-names>PD</given-names></name>. <article-title>HIV Restriction Factors and Mechanisms of Evasion</article-title>. <source>Cold Spring Harb Perspect Med</source>. <year>2012</year>; <volume>2</volume>: <fpage>a006940</fpage>–<lpage>a006940</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a006940" xlink:type="simple">10.1101/cshperspect.a006940</ext-link></comment> <object-id pub-id-type="pmid">22553496</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref085"><label>85</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saito</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Akari</surname> <given-names>H</given-names></name>. <article-title>Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors</article-title>. <source>Front Microbiol. Frontiers</source>; <year>2013</year>; <volume>4</volume>: <fpage>187</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2013.00187" xlink:type="simple">10.3389/fmicb.2013.00187</ext-link></comment> <object-id pub-id-type="pmid">23847610</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref086"><label>86</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>LI</given-names></name>, <name name-style="western"><surname>Emerman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Malik</surname> <given-names>HS</given-names></name>. <article-title>Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2005</year>; <volume>102</volume>: <fpage>2832</fpage>–<lpage>2837</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0409853102" xlink:type="simple">10.1073/pnas.0409853102</ext-link></comment> <object-id pub-id-type="pmid">15689398</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref087"><label>87</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Emerman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Malik</surname> <given-names>HS</given-names></name>. <article-title>Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G</article-title>. <source>PLoS Biol</source>. <year>2004</year>; <volume>2</volume>: <fpage>E275</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.0020275" xlink:type="simple">10.1371/journal.pbio.0020275</ext-link></comment> <object-id pub-id-type="pmid">15269786</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref088"><label>88</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McNatt</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Zang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hatziioannou</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Bartlett</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fofana</surname> <given-names>IB</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>WE</given-names></name>, <etal>et al</etal>. <article-title>Species-Specific Activity of HIV-1 Vpu and Positive Selection of Tetherin Transmembrane Domain Variants</article-title>. <source>PLoS Pathog</source>. <year>2009</year>; <volume>5</volume>: <fpage>e1000300</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1000300" xlink:type="simple">10.1371/journal.ppat.1000300</ext-link></comment> <object-id pub-id-type="pmid">19214216</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref089"><label>89</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lim</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Malik</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Emerman</surname> <given-names>M</given-names></name>. <article-title>Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses</article-title>. <source>J Virol</source>. <year>2010</year>; <volume>84</volume>: <fpage>7124</fpage>–<lpage>7134</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00468-10" xlink:type="simple">10.1128/JVI.00468-10</ext-link></comment> <object-id pub-id-type="pmid">20444900</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref090"><label>90</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Longdon</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Brockhurst</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Russell</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Welch</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Jiggins</surname> <given-names>FM</given-names></name>. <article-title>The evolution and genetics of virus host shifts</article-title>. <source>PLoS Pathog</source>. <year>2014</year>; <volume>10</volume>: <fpage>e1004395</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1004395" xlink:type="simple">10.1371/journal.ppat.1004395</ext-link></comment> <object-id pub-id-type="pmid">25375777</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref091"><label>91</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woolhouse</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Scott</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Hudson</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Howey</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Chase-Topping</surname> <given-names>M</given-names></name>. <article-title>Human viruses: discovery and emergence</article-title>. <source>Phil Trans R Soc B</source>. <year>2012</year>; <volume>367</volume>: <fpage>2864</fpage>–<lpage>2871</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1098/rstb.2011.0354" xlink:type="simple">10.1098/rstb.2011.0354</ext-link></comment> <object-id pub-id-type="pmid">22966141</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref092"><label>92</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>S-K</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Kuhn</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>I-C</given-names></name>, <name name-style="western"><surname>Choe</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions</article-title>. <source>J Virol</source>. <year>2006</year>; <volume>80</volume>: <fpage>4211</fpage>–<lpage>4219</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.80.9.4211-4219.2006" xlink:type="simple">10.1128/JVI.80.9.4211-4219.2006</ext-link></comment> <object-id pub-id-type="pmid">16611880</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref093"><label>93</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fedeli</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Moreno</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kunz</surname> <given-names>S</given-names></name>. <article-title>Novel Insights into Cell Entry of Emerging Human Pathogenic Arenaviruses</article-title>. <source>J Mol Biol</source>. <year>2018</year>; <volume>430</volume>: <fpage>1839</fpage>–<lpage>1852</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jmb.2018.04.026" xlink:type="simple">10.1016/j.jmb.2018.04.026</ext-link></comment> <object-id pub-id-type="pmid">29705070</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref094"><label>94</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kailasan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Agbandje-McKenna</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Parrish</surname> <given-names>CR</given-names></name>. <article-title>Parvovirus Family Conundrum: What Makes a Killer?</article-title> <source>Annu Rev Virol</source>. <year>2015</year>; <volume>2</volume>: <fpage>425</fpage>–<lpage>450</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev-virology-100114-055150" xlink:type="simple">10.1146/annurev-virology-100114-055150</ext-link></comment> <object-id pub-id-type="pmid">26958923</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref095"><label>95</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arrildt</surname> <given-names>KT</given-names></name>, <name name-style="western"><surname>LaBranche</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Joseph</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Dukhovlinova</surname> <given-names>EN</given-names></name>, <name name-style="western"><surname>Graham</surname> <given-names>WD</given-names></name>, <name name-style="western"><surname>Ping</surname> <given-names>L-H</given-names></name>, <etal>et al</etal>. <article-title>Phenotypic Correlates of HIV-1 Macrophage Tropism</article-title>. <source>J Virol</source>. <year>2015</year>; <volume>89</volume>: <fpage>11294</fpage>–<lpage>11311</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00946-15" xlink:type="simple">10.1128/JVI.00946-15</ext-link></comment> <object-id pub-id-type="pmid">26339058</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref096"><label>96</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dunfee</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Thomas</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>Gorry</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kunstman</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2006</year>;<volume>103</volume>: <fpage>15160</fpage>–<lpage>15165</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0605513103" xlink:type="simple">10.1073/pnas.0605513103</ext-link></comment> <object-id pub-id-type="pmid">17015824</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref097"><label>97</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Laguette</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Sobhian</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Casartelli</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ringeard</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chable-Bessia</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ségéral</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx</article-title>. <source>Nature</source>. <year>2011</year>; <volume>474</volume>: <fpage>654</fpage>–<lpage>657</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature10117" xlink:type="simple">10.1038/nature10117</ext-link></comment> <object-id pub-id-type="pmid">21613998</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref098"><label>98</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berger</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Durand</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Fargier</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>X-N</given-names></name>, <name name-style="western"><surname>Cordeil</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bouaziz</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells</article-title>. <source>PLoS Pathog</source>. <year>2011</year>; <volume>7</volume>: <fpage>e1002221</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1002221" xlink:type="simple">10.1371/journal.ppat.1002221</ext-link></comment> <object-id pub-id-type="pmid">21966267</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref099"><label>99</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O'Brien</surname> <given-names>WA</given-names></name>, <name name-style="western"><surname>Namazi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kalhor</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Mao</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Zack</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>IS</given-names></name>. <article-title>Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors</article-title>. <source>J Virol</source>. <year>1994</year>; <volume>68</volume>: <fpage>1258</fpage>–<lpage>1263</lpage>. <object-id pub-id-type="pmid">7507180</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref100"><label>100</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arfi</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Rivière</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Jarrosson-Wuillème</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Goujon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Rigal</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Darlix</surname> <given-names>J-L</given-names></name>, <etal>et al</etal>. <article-title>Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1</article-title>. <source>J Virol</source>. <year>2008</year>; <volume>82</volume>: <fpage>6557</fpage>–<lpage>6565</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02321-07" xlink:type="simple">10.1128/JVI.02321-07</ext-link></comment> <object-id pub-id-type="pmid">18417568</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref101"><label>101</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kilareski</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Shah</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nonnemacher</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Wigdahl</surname> <given-names>B</given-names></name>. <article-title>Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage</article-title>. <source>Retrovirology</source>. <year>2009</year>; <volume>6</volume>: <fpage>118</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1742-4690-6-118" xlink:type="simple">10.1186/1742-4690-6-118</ext-link></comment> <object-id pub-id-type="pmid">20030845</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref102"><label>102</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Joseph</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Arrildt</surname> <given-names>KT</given-names></name>, <name name-style="western"><surname>Sturdevant</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Swanstrom</surname> <given-names>R</given-names></name>. <article-title>HIV-1 target cells in the CNS</article-title>. <source>J Neurovirol</source>. <year>2015</year>; <volume>21</volume>: <fpage>276</fpage>–<lpage>289</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13365-014-0287-x" xlink:type="simple">10.1007/s13365-014-0287-x</ext-link></comment> <object-id pub-id-type="pmid">25236812</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref103"><label>103</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schnell</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Joseph</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Spudich</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Price</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Swanstrom</surname> <given-names>R</given-names></name>. <article-title>HIV-1 replication in the central nervous system occurs in two distinct cell types</article-title>. <source>PLoS Pathog</source>. <year>2011</year>; <volume>7</volume>: <fpage>e1002286</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1002286" xlink:type="simple">10.1371/journal.ppat.1002286</ext-link></comment> <object-id pub-id-type="pmid">22007152</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref104"><label>104</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cherner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Masliah</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Ellis</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Marcotte</surname> <given-names>TD</given-names></name>, <name name-style="western"><surname>Moore</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Grant</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis</article-title>. <source>Neurology</source>. <year>2002</year>; <volume>59</volume>: <fpage>1563</fpage>–<lpage>1567</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/01.wnl.0000034175.11956.79" xlink:type="simple">10.1212/01.wnl.0000034175.11956.79</ext-link></comment> <object-id pub-id-type="pmid">12451198</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref105"><label>105</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Antinori</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Arendt</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Becker</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Brew</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Byrd</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Cherner</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Updated research nosology for HIV-associated neurocognitive disorders</article-title>. <source>Neurology</source>. <year>2007</year>; <volume>69</volume>: <fpage>1789</fpage>–<lpage>1799</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/01.WNL.0000287431.88658.8b" xlink:type="simple">10.1212/01.WNL.0000287431.88658.8b</ext-link></comment> <object-id pub-id-type="pmid">17914061</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref106"><label>106</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sugimoto</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Arainga</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Midkiff</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>DX</given-names></name>, <name name-style="western"><surname>Alvarez</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Preferential Destruction of Interstitial Macrophages over Alveolar Macrophages as a Cause of Pulmonary Disease in Simian Immunodeficiency Virus-Infected Rhesus Macaques</article-title>. <source>J Immunol</source>. <year>2015</year>; <volume>195</volume>: <fpage>4884</fpage>–<lpage>4891</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1501194" xlink:type="simple">10.4049/jimmunol.1501194</ext-link></comment> <object-id pub-id-type="pmid">26432896</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref107"><label>107</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crowe</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Westhorpe</surname> <given-names>CLV</given-names></name>, <name name-style="western"><surname>Mukhamedova</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Jaworowski</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sviridov</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Bukrinsky</surname> <given-names>M</given-names></name>. <article-title>The macrophage: the intersection between HIV infection and atherosclerosis</article-title>. <source>J Leukoc Biol</source>. <year>2010</year>; <volume>87</volume>: <fpage>589</fpage>–<lpage>598</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1189/jlb.0809580" xlink:type="simple">10.1189/jlb.0809580</ext-link></comment> <object-id pub-id-type="pmid">19952353</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref108"><label>108</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stremlau</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Owens</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Perron</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Kiessling</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Autissier</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sodroski</surname> <given-names>J</given-names></name>. <article-title>The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys</article-title>. <source>Nature</source>. <year>2004</year>; <volume>427</volume>: <fpage>848</fpage>–<lpage>853</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature02343" xlink:type="simple">10.1038/nature02343</ext-link></comment> <object-id pub-id-type="pmid">14985764</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref109"><label>109</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyerson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Warren</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Vieira</surname> <given-names>DASA</given-names></name>, <name name-style="western"><surname>Diaz-Griferro</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Sawyer</surname> <given-names>SL</given-names></name>. <article-title>Species-specific vulnerability of RanBP2 shaped the evolution of SIV as it transmitted in African apes</article-title>. <source>PLoS Pathog</source>. <year>2018</year>;<volume>14</volume>: <fpage>e1006906</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1006906" xlink:type="simple">10.1371/journal.ppat.1006906</ext-link></comment> <object-id pub-id-type="pmid">29518153</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref110"><label>110</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stabell</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Hawkins</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>David</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Press</surname> <given-names>WH</given-names></name>, <etal>et al</etal>. <article-title>Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral Proteins</article-title>. <source>PLoS Pathog</source>. <year>2016</year>; <volume>12</volume>: <fpage>e1006066</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1006066" xlink:type="simple">10.1371/journal.ppat.1006066</ext-link></comment> <object-id pub-id-type="pmid">28027315</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref111"><label>111</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nisole</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lynch</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Stoye</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Yap</surname> <given-names>MW</given-names></name>. <article-title>A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2004</year>; <volume>101</volume>: <fpage>13324</fpage>–<lpage>13328</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0404640101" xlink:type="simple">10.1073/pnas.0404640101</ext-link></comment> <object-id pub-id-type="pmid">15326303</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref112"><label>112</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sayah</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Sokolskaja</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Berthoux</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Luban</surname> <given-names>J</given-names></name>. <article-title>Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1</article-title>. <source>Nature</source>. <year>2004</year>; <volume>430</volume>: <fpage>569</fpage>–<lpage>573</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature02777" xlink:type="simple">10.1038/nature02777</ext-link></comment> <object-id pub-id-type="pmid">15243629</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref113"><label>113</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cyranoski</surname> <given-names>D</given-names></name>. <article-title>Monkey kingdom</article-title>. <source>Nature</source>. <year>2016</year>. <volume>532</volume> (<issue>7599</issue>): <fpage>300</fpage>–<lpage>302</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/532300a" xlink:type="simple">10.1038/532300a</ext-link></comment> <object-id pub-id-type="pmid">27111614</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref114"><label>114</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyerson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>YR</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tao</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Krug</surname> <given-names>RM</given-names></name>, <etal>et al</etal>. <article-title>Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation</article-title>. <source>Cell Host Microbe</source>. <year>2017</year>; <volume>22</volume>: 627–638.e7. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chom.2017.10.003" xlink:type="simple">10.1016/j.chom.2017.10.003</ext-link></comment> <object-id pub-id-type="pmid">29107643</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref115"><label>115</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lou</surname> <given-names>DI</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>ET</given-names></name>, <name name-style="western"><surname>Meyerson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Pancholi</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Mohni</surname> <given-names>KN</given-names></name>, <name name-style="western"><surname>Enard</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>An Intrinsically Disordered Region of the DNA Repair Protein Nbs1 Is a Species-Specific Barrier to Herpes Simplex Virus 1 in Primates</article-title>. <source>Cell Host Microbe</source>. <year>2016</year>; <volume>20</volume>: <fpage>178</fpage>–<lpage>188</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chom.2016.07.003" xlink:type="simple">10.1016/j.chom.2016.07.003</ext-link></comment> <object-id pub-id-type="pmid">27512903</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref116"><label>116</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stabell</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Meyerson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Gullberg</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Gilchrist</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Old</surname> <given-names>WM</given-names></name>, <etal>et al</etal>. <article-title>Dengue viruses cleave STING in humans but not in nonhuman primates, their presumed natural reservoir</article-title>. <source>eLife</source>. <year>2018</year>; <volume>7</volume>: <fpage>e01081</fpage>–<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.31919" xlink:type="simple">10.7554/eLife.31919</ext-link></comment> <object-id pub-id-type="pmid">29557779</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref117"><label>117</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zeng</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Species-Specific Deamidation of cGAS by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication</article-title>. <source>Cell Host Microbe</source>. <year>2018</year>; <volume>24</volume>: 234–248.e5. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chom.2018.07.004" xlink:type="simple">10.1016/j.chom.2018.07.004</ext-link></comment> <object-id pub-id-type="pmid">30092200</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref118"><label>118</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Long</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Rainwater</surname> <given-names>SMJ</given-names></name>, <name name-style="western"><surname>Lavreys</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Mandaliya</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Overbaugh</surname> <given-names>J</given-names></name>. <article-title>HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>2002</year>; <volume>18</volume>: <fpage>567</fpage>–<lpage>576</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/088922202753747914" xlink:type="simple">10.1089/088922202753747914</ext-link></comment> <object-id pub-id-type="pmid">12036486</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref119"><label>119</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aricescu</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>EY</given-names></name>. <article-title>A time- and cost-efficient system for high-level protein production in mammalian cells</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>. <year>2006</year>; <volume>62</volume>: <fpage>1243</fpage>–<lpage>1250</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1107/S0907444906029799" xlink:type="simple">10.1107/S0907444906029799</ext-link></comment> <object-id pub-id-type="pmid">17001101</object-id></mixed-citation></ref>
<ref id="pbio.3000304.ref120"><label>120</label><mixed-citation publication-type="book" xlink:type="simple"><collab>National Research Council (U.S.)</collab>. <collab>Committee for the update of the Guide for the Care and Use of Laboratory Animals., Institute or Laboratory Animal Research (U.S.)</collab>, <publisher-name>National Academies Press (U.S.)</publisher-name>. <year>2011</year>. <source>Guide for the care and use of laboratory animals</source>, <edition>8th ed</edition>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1258/la.2010.010031" xlink:type="simple">10.1258/la.2010.010031</ext-link></comment></mixed-citation></ref>
</ref-list>
</back>
</article>